liverpool
unit
kingdom
septemb
list
oral
research
commun
p
sl
v
pj
aj
liverpool
wirral
unit
canin
research
center
aimargu
centr
pet
nutrit
unit
kingdom
veterinarian
use
bodi
condit
score
estim
adipos
cat
correl
well
bodi
fat
mass
measur
absorptiometri
dexa
howev
techniqu
score
lay
peopl
least
reliabl
bodi
condit
could
reliabl
estim
photograph
might
feasibl
develop
remot
screen
tool
ie
internet
web
page
smart
phone
applic
wherebi
photograph
upload
review
expert
howev
feasibl
use
photograph
determin
bodi
composit
never
assess
cat
photograph
overweight
obes
cat
refer
royal
canin
weight
manag
clinic
univers
liverpool
uk
review
imag
taken
weight
loss
use
enabl
cat
ideal
condit
bc
overweight
bc
obes
bc
examin
eleven
observ
rang
experi
examin
photograph
estim
bodi
condit
ibc
use
two
method
standardis
assess
pair
dorsal
later
imag
taken
grid
use
standardis
posit
ibcsdl
subject
estim
bodi
condit
photograph
standardis
posit
ibcssub
result
compar
bodi
fat
percentag
measur
dexa
actual
bc
assess
experienc
oper
moder
signific
posit
associationswer
seen
bodi
fat
percentag
method
albeit
mark
differ
amongst
oper
ibcsdl
median
kendal
tau
ibcssubmedian
kendal
tau
overal
agreement
actual
bc
method
bc
ibcsdlmedian
kappa
p
ibcssub
median
kappa
oper
score
similar
percentag
cat
correctli
method
ibcssubmedian
p
age
sex
breed
coat
length
coat
colour
oper
experi
effect
perform
either
method
p
howev
bodi
fat
percentag
posit
associ
number
correctli
score
use
ibcssubmethod
kendal
tau
p
use
ibcsdl
kendal
tau
p
approxim
estim
bodi
composit
obtain
photograph
cat
although
wide
oper
variabl
exist
margin
less
use
standardis
imag
assess
conflict
interest
conflict
interest
report
pelizzola
gruarin
l
conti
r
giunti
f
dondi
alma
mater
studiorum
univers
bologna
ozzano
dellemilia
bo
itali
proteinuria
consid
marker
kidney
damag
dog
urin
dipstick
test
urinari
protein
creatinin
ratio
upc
commonli
use
diagnos
monitor
proteinur
patient
clinic
practic
human
urinari
albumin
creatinin
ratio
uac
repres
gold
standard
method
earli
renal
diseas
detect
moreov
albuminuria
associ
chronic
kidney
diseas
ckd
progress
mortal
aim
studi
evalu
abil
urin
dipstick
test
upc
earli
recogn
albuminur
dog
canin
urin
sampl
without
activ
sediment
macroscop
hematuria
collect
januari
decemb
teach
hospit
urinalysi
upc
uac
avail
sampl
upc
uac
perform
specimen
urin
sampl
dipstick
test
use
autom
reader
consid
uac
immunoturbidimetr
assay
refer
method
diagnost
accuraci
dipstick
test
upc
pyrogallol
molybd
evalu
uac
refer
interv
determin
healthi
dog
data
collect
categor
use
differ
urin
specif
graviti
dipstick
proteinuria
mgdl
upc
uac
diagnost
agreement
cohen
k
coeffici
spearman
correl
dipstick
upc
uac
evalu
diagnost
accuraci
estim
area
roc
curv
auc
analysi
signific
level
set
p
independ
urin
concentr
diagnost
agreement
dipstick
upc
uac
substanti
k
k
respect
p
posit
dipstick
result
mgdl
fair
k
k
respect
p
posit
dipstick
result
mgdl
diagnost
accuraci
dipstick
compar
upc
uac
good
auc
respect
p
neg
dipstick
result
present
sensit
upc
uac
highli
correl
r
p
compar
upc
uac
diagnost
accuraci
excel
auc
p
maximum
sensit
specif
upc
conclus
urin
densiti
posit
dipstick
result
mgdl
probabl
detect
albuminuria
outsid
refer
interv
upc
uac
assess
contrast
sampl
neg
dipstick
result
unlik
proteinur
albuminur
furthermor
upc
could
use
detect
albuminur
canin
patient
earli
kidney
damag
use
threshold
lower
studi
requir
clarifi
use
uac
veterinari
clinic
practic
conflict
interest
conflict
interest
report
f
manczur
n
kubik
faculti
veterinari
scienc
szent
univers
budapest
hungari
endothelin
et
amino
acid
vasoact
peptid
endocrin
paracrin
autocrin
effect
kidney
endogen
et
control
water
sodium
excret
balanc
maintain
normal
renal
cell
prolifer
tonic
vasoconstrict
physiolog
condit
increas
et
synthesi
caus
intraren
vasoconstrict
mesanchym
cell
prolifer
hypertrophi
contract
extracellular
matrix
accumul
effect
induc
glomerular
damag
lead
renal
inflammatori
process
fibrosi
sinc
et
caus
vasoconstrict
sodium
water
retent
potenti
rais
blood
pressur
kidney
patient
mani
laboratori
anim
studi
observ
human
clinic
patient
prove
patholog
role
et
hypertens
variou
renal
disord
almost
et
detect
urin
origin
kidney
mostli
medulla
accordingli
assess
urinari
et
excret
circul
et
concentr
strongli
suggest
possibl
marker
earli
renal
damag
aim
research
measur
urinari
et
concentr
spontan
acut
chronic
renal
diseas
dog
forti
three
urin
sampl
obtain
ultrasound
guid
cystocentesi
dog
diagnost
seven
anim
healthi
suffer
variou
renal
diseas
hypertens
renal
extraren
origin
measur
perform
human
commerci
accord
manufactur
protocol
urinari
et
concentr
express
normal
urinari
creatinin
level
studi
found
strongest
associ
urinari
et
sodium
concentr
fraction
excret
sodium
weaker
associ
degre
proteinuria
urinari
et
level
howev
proteinur
dog
significantli
higher
urinari
et
creatinin
ratio
anim
azotaem
dog
also
significantli
higher
urinari
et
concentr
one
associ
urinari
et
express
degre
azotaemia
associ
found
urinari
et
level
system
blood
pressur
result
support
previou
data
role
renal
et
synthesi
sodium
handl
kidney
found
associ
proteinuria
renal
diseas
urinari
et
excret
confirm
larger
studi
popul
conflict
interest
conflict
interest
report
ac
j
hm
jl
nephrolog
unit
univers
sheffield
sheffield
unit
veterinari
basic
scienc
royal
veterinari
colleg
london
unit
veterinari
clinic
scienc
royal
veterinari
colleg
london
unit
kingdom
chronic
kidney
diseas
ckd
major
caus
morbid
mortal
cat
transglutaminas
enzym
propos
mediat
tubulointerstiti
fibrosi
irrevers
collagen
fibril
kidney
tissu
analys
cat
either
ckd
base
plasma
creatinin
concentr
n
without
renal
azotaemia
n
ckd
cat
stage
accord
intern
renal
interest
societi
rang
stage
b
kidney
assess
extracellular
matrix
protein
deposit
masson
trichrom
stain
collagen
immunofluoresc
total
kidney
tg
enzym
activ
total
protein
measur
tissu
homogen
putrescin
incorpor
western
blot
respect
quantifi
kda
band
western
blot
detect
use
polyclon
rabbit
antibodi
extracellular
tg
enzym
activ
extracellular
protein
determin
situ
fluoresc
label
streptavidin
tg
substrat
immunofluoresc
respect
use
cryostat
section
data
analyz
unpair
welch
correct
evalu
group
correl
calcul
linear
regress
analysi
level
statist
signific
defin
p
elev
plasma
creatinin
urea
phosphat
concentr
associ
tubulointerstiti
fibrosi
glomerular
fibrosi
homogen
studi
show
approxim
greater
total
tg
enzym
activ
vs
nmol
putrescin
per
hour
p
total
protein
vs
od
protein
p
azotem
group
compar
group
fluoresc
studi
perform
situ
confirm
increas
extracellular
tg
enzym
activ
vs
area
p
extracellular
protein
vs
area
p
cat
azotaem
ckd
tubulointerstiti
show
highli
signific
posit
linear
correl
plasma
concentr
creatinin
p
urea
p
phosphat
p
signific
posit
linear
correl
could
also
demonstr
masson
trichrom
stain
p
abund
type
collagen
p
cat
azotaem
ckd
filtrat
failur
tubulointerstiti
fibrosi
associ
upregul
enzym
major
tg
isoform
kidney
may
provid
new
therapeut
target
drug
design
stop
slow
progress
felin
ckd
conflict
interest
conflict
interest
report
tl
c
royal
dick
school
veterinari
studi
edinburgh
unit
anim
medic
center
new
york
citi
unit
state
america
urethr
obstruct
benign
diseas
uncommonli
report
dog
result
signific
morbid
mortal
due
challeng
convent
therapi
treatment
malign
urethr
obstruct
intralumin
urethr
stent
report
success
reliev
obstruct
retrospect
studi
investig
urethr
stent
placement
dog
benign
urethr
obstruct
treat
author
practic
data
collect
includ
signal
caus
benign
obstruct
procedur
time
size
type
stent
complic
outcom
eleven
dog
includ
analysi
intralumin
urethr
stent
reliev
obstruct
dog
three
dog
two
stent
place
separ
procedur
due
incomplet
patenc
treatment
tissu
ingrowth
stent
periop
complic
dog
four
dog
mild
incontin
follow
stent
placement
one
dog
moder
sever
incontin
signific
associ
sex
durat
clinic
sign
length
stent
diamet
stent
incontin
one
dog
develop
mild
stranguria
stent
placement
ten
dog
excel
outcom
month
treatment
one
dog
develop
lymphoma
euthan
month
treatment
one
dog
chronic
urinari
tract
infect
present
prior
stent
placement
urethr
stent
appear
effect
treatment
benign
urinari
obstruct
moder
sever
incontin
develop
dog
stent
reliev
obstruct
dog
good
excel
outcom
dog
conflict
interest
conflict
interest
report
f
jh
mf
g
cm
arcueil
vebio
arcueil
franc
emerg
multipl
mdr
bacteria
grow
public
health
problem
human
certain
number
factor
promot
onset
infect
mdr
pathogen
identifi
age
patient
hospitalis
within
past
year
administr
antibiot
within
past
year
dog
demonstr
proport
escherichia
coli
isol
rectum
resist
least
one
antibiot
increas
day
hospitalis
univers
intens
care
unit
object
retrospect
studi
identifi
risk
factor
associ
mdr
e
coli
infect
urinari
tract
cat
cat
present
e
coli
urinari
infect
march
decemb
centr
hospitali
franc
divid
two
group
mdr
group
group
isol
resist
antimicrobi
class
consid
mdr
effect
differ
variabl
occurr
mdr
e
coli
evalu
age
sex
addit
diseas
number
antibiot
number
day
hospitalis
cat
identifi
mdr
number
antibiot
famili
use
within
last
month
associ
increas
risk
mdr
e
coli
urinari
infect
p
trend
number
day
hospitalis
within
last
month
increas
risk
mdr
e
coli
urinari
infect
also
found
p
studi
provid
evid
systemat
urinari
cultur
antibiot
sensit
test
recommend
treat
urinari
tract
infect
antibiot
prescrib
within
past
month
moreov
select
mdr
bacteria
antibiot
use
consid
potenti
risk
associ
treatment
conflict
interest
conflict
interest
report
c
ea
l
r
ospedal
per
animali
da
compagnia
moncalieri
compar
biomedicin
food
scienc
univers
padua
padua
oslo
norway
kidney
diseas
histor
term
juvenil
renal
dysplasia
found
sever
dog
breed
boxer
renal
lesion
term
juvenil
nephropathi
describ
howev
literaratur
topic
limit
differ
theori
pathogenesi
propos
one
studi
data
boxer
younger
five
year
collect
retrospect
dog
show
azotaemia
inappropri
low
urin
concentr
abil
ultrasound
radiograph
evid
abnorm
kidney
renal
histopatholog
find
includ
pericapsular
interstiti
fibrosi
inflammatori
cell
infiltr
dilat
tubul
sclerot
glomeruli
dystroph
calcif
chandler
anoth
studi
includ
seven
young
boxer
author
conclud
kidney
diseas
eskd
like
result
chronic
reflux
nephropathi
caus
segment
hypoplasia
kidney
aim
present
studi
twofold
describ
light
microscopi
lesion
popul
boxer
evalu
clinic
find
compar
publish
data
boxer
dog
chronic
kidney
diseas
ckd
retrospect
evalu
kidney
biopsi
clinic
data
seventeen
boxer
enrol
ckd
iri
stage
age
rang
year
dog
evalu
use
biochemistri
cbc
urinalysi
urin
cultur
blood
pressur
renal
ultrasound
clinic
data
avail
extend
period
eight
dog
renal
lesion
associ
juvenil
nephropathi
base
presenc
immatur
fetal
glomeruli
histopatholog
find
includ
increas
mesangi
matrix
cell
glomerulosclerosi
interstiti
fibrosi
tubular
atrophi
immun
deposit
observ
exclud
immun
mediat
origin
diseas
strike
featur
high
number
cystic
glomerular
atrophi
alter
morpholog
glomeruli
character
sever
podocyt
hypertrophi
split
bowman
capsul
multipl
synechia
three
dog
leishmania
one
dog
renal
lymphoma
one
dog
chronic
urinari
tract
infect
four
dog
nonspecif
eskd
clinicopatholog
find
characterist
progress
ckd
pupd
weight
loss
anorexia
sometim
vomit
diarrhea
anemia
hyperphosphatemia
nine
dog
hypertens
dog
proteinur
upc
rang
fourteen
dog
isosthenuria
dog
cylinduria
averag
plasma
creatinin
time
biopsi
mgdl
pathophysiolog
juvenil
renal
diseas
boxer
need
elucid
conflict
interest
conflict
interest
report
j
ben
n
g
school
veterinari
medicin
hebrew
univers
jerusalem
rehovot
clinic
herzelia
israel
renal
hematuria
uncommon
caus
hematuira
dog
recent
identifi
chronic
renal
hematuria
unknown
caus
golden
retriev
retrospect
studi
aim
character
histori
physic
examin
clinicopatholog
ultrasonograph
histopatholog
find
well
diseas
progress
prognosi
affect
dog
twenti
client
own
golden
retriev
present
hebrew
univers
veterinari
teach
hospit
complaint
persist
hemeturia
day
intermitt
hematuria
year
includ
data
collect
medic
record
follow
data
obtain
via
telephon
interview
recheck
teach
hospit
refer
veterinarian
median
age
onset
hematuria
month
rang
one
third
dog
present
hematuria
year
age
younger
bleed
episod
last
median
month
rang
day
month
hematuria
present
time
dog
median
hematocrit
creatinin
concentr
upc
present
rang
mgdl
rang
n
rang
respect
renal
ultrasounograph
abnorm
document
dog
includ
mottl
area
poor
corticomedullari
definit
hyperechogen
heterogen
mass
median
time
dog
month
rang
eleven
dog
still
aliv
median
creatinin
concentr
last
follow
mgdl
dog
develop
azotemia
qualiti
life
grade
relat
mostli
concurr
diseas
despit
persist
sever
hematuria
dog
requir
blood
transfus
six
dog
dead
euthan
due
progress
renal
diseas
one
due
persist
hematuria
other
due
unrel
caus
histopatholog
avail
dog
abnorm
includ
cortic
interstiti
fibrosi
hematoidin
accumul
tubular
epithelium
focal
interstiti
nephriti
presenc
amorph
materi
brown
macrophag
tubul
first
report
renal
hematuria
golden
retriev
despit
persist
hematuria
hematocrit
remain
stabl
blood
transfus
rare
requir
although
ultrasonograph
chang
common
occasion
sever
kidney
function
remain
stabl
good
qualiti
life
longev
maintain
mode
inherit
disord
need
farther
investig
larger
scale
survey
warrant
assess
preval
disord
conflict
interest
conflict
interest
report
p
l
j
hp
ghent
faculti
veterinari
medicin
merelbek
ghent
faculti
medicin
health
scienc
ghent
national
de
toulous
toulous
franc
glomerular
tubular
alter
describ
dog
cush
syndrom
diabet
mellitu
earli
diagnosi
renal
dysfunct
crucial
routin
renal
marker
insensit
gfr
measur
new
renal
marker
serum
cystatin
c
scysc
use
gfr
marker
human
nephrolog
gain
much
interest
inform
scysc
dog
scarc
studi
aim
valid
nephelometr
assay
canin
scysc
measur
evalu
scysc
dog
dm
cs
renal
function
monitor
dog
cs
dog
dm
month
respect
baselin
data
collect
seventeen
healthi
dog
compar
age
bodyweight
serum
creatinin
scr
serum
urea
urinari
ratio
upc
determin
analyt
valid
scysc
level
measur
nephelometr
immuno
assay
penia
use
human
bn
prospec
analyz
combin
plasma
exogen
clearanc
test
perform
determin
gfr
previous
describ
penia
measur
cysc
linear
precis
manner
coeffici
variat
cv
cv
signific
invers
effect
creatinin
clearanc
scysc
found
whole
group
p
compar
dm
healthi
group
signific
higher
percentag
cs
dog
proteinuria
upc
baselin
p
signific
differ
found
group
scysc
gfr
baselin
clinic
relev
chang
observ
scr
time
percent
diabet
dog
persist
proteinuria
despit
treatment
cs
group
signific
decreas
upc
ratio
observ
initi
treatment
p
although
persist
proteinuria
although
signific
decreas
time
observ
scysc
within
dm
group
p
signific
chang
observ
scysc
level
within
cs
group
signific
decreas
observ
gfr
within
cs
group
p
signific
chang
gfr
found
within
dm
group
result
show
penia
valid
method
measur
scysc
dog
cysc
could
use
gfr
marker
although
current
studi
could
enhanc
research
determin
use
scysc
dog
necessari
declin
gfr
dog
cs
persist
proteinuria
dog
cs
dm
warrant
clinician
attent
conflict
interest
conflict
interest
report
p
watson
read
c
univers
cambridg
cambridg
unit
kingdom
skye
terrier
hepat
first
report
nine
relat
dog
singl
case
report
sinc
accumul
copper
liver
differ
copper
storag
diseas
breed
disord
intracanalicular
cholestasi
propos
entir
male
skye
terrier
intend
stud
dog
present
first
author
investig
week
histori
inappet
lethargi
ascit
investig
reveal
elev
pancreat
liver
enzym
mark
hypoalbuminaemia
abdomin
transud
normal
coagul
time
biopsi
liver
pancrea
taken
bile
cytolog
cultur
neg
pancrea
section
histolog
unremark
liver
normal
area
exhibit
moder
small
irregular
bile
duct
prolifer
endotheli
hyperplasia
reduc
portal
vein
profil
fibrosi
grossli
abnorm
area
hepatocyt
replac
almost
entir
larg
amount
fibrou
tissu
admix
larg
number
small
bile
duct
inflamm
minim
scatter
cluster
brown
pigment
laden
macrophag
hepatocyt
present
multifoc
perl
stain
haemosiderin
strongli
posit
area
rhodanin
stain
copper
bile
plug
green
pigment
within
canaliculi
fouchet
stain
posit
present
histolog
find
consist
previous
report
juvenil
hepat
fibrosi
dog
light
find
liver
relat
dog
year
old
femal
breeder
examin
post
mortem
dog
show
similar
sever
chang
mark
biliari
hyperplasia
abnorm
bile
duct
profil
within
larg
tract
fibrou
tissu
perl
rhodanin
stain
show
mark
accumul
iron
copper
find
consist
juvenil
hepat
fibrosi
question
breeder
reveal
mother
first
case
clinic
diagnosi
cirrhosi
still
aliv
hepat
histolog
anecdot
also
report
juvenil
renal
diseas
young
adult
relat
skye
terrier
previous
describ
find
strongli
suggest
inherit
ductal
plate
abnorm
liver
skye
terrier
inconsist
origin
publish
report
could
explain
secondari
accumul
iron
copper
studi
underway
obtain
liver
kidney
tissu
affect
dog
stain
liver
cytokeratin
juvenil
bile
duct
conflict
interest
conflict
interest
report
h
vc
tsgam
van
den
al
paj
j
veterinari
medicin
utrecht
canin
research
centr
aimargu
consult
bv
utrecht
netherland
introduct
copper
associ
hepat
labrador
retriev
hereditari
diseas
genet
factor
environment
factor
like
dietari
intak
copper
zinc
play
role
hepat
copper
accumul
accompani
inflammatori
infiltr
copper
level
typic
mgkg
dri
weight
liver
first
present
chelat
therapi
initi
treatment
choic
howev
lifelong
continu
chelat
therapi
carri
risk
overtreat
breed
may
lead
unwant
low
bodi
copper
zinc
aim
current
studi
evalu
use
low
copper
high
zinc
diet
long
term
manag
copper
associ
hepat
labrador
retriev
method
sixteen
labrador
retriev
affect
copper
associ
hepat
studi
longitudin
normal
hepat
copper
due
treatment
dog
maintain
low
copper
high
zinc
diet
liver
biopsi
taken
everi
month
measur
hepat
copper
concentr
histolog
evalu
hepat
fibrosi
result
conclus
observ
variat
rate
hepat
copper
dietari
treatment
alon
suffici
maintain
hepat
copper
concentr
safe
level
major
dog
follow
period
rang
month
dog
four
dog
need
median
follow
period
month
rang
month
hepat
copper
accompani
worsen
hepat
grade
stage
fibrosi
propos
use
combin
dietari
treatment
altern
dietari
treatment
alon
good
strategi
manag
labrador
retriev
affect
copper
associ
hepat
conflict
interest
adrian
watson
vincent
biourg
employ
royal
canin
financi
support
studi
provid
diet
use
studi
rodrigu
jk
js
jm
univers
colleg
station
unit
state
coast
veterinari
specialist
houston
unit
state
america
serum
biomark
hepat
fibrosi
develop
use
human
patient
type
iii
peptid
piiinp
compon
extracellular
matrix
fibrosi
greater
amount
protein
releas
blood
stream
due
increas
rate
extracellular
matrix
turnov
human
report
sensit
specif
serum
piiinp
concentr
differenti
patient
mild
hepat
fibrosi
moder
sever
hepat
fibrosi
rang
respect
aim
studi
assess
util
piiinp
biomark
canin
hepat
fibrosi
serum
sampl
dog
hepat
diseas
collect
divid
group
follow
dog
chronic
hepat
hepat
neoplasia
congenit
portosystem
shunt
hepatobiliari
diseas
liver
biopsi
specimen
dog
avail
assess
serum
sampl
healthi
control
dog
also
collect
hepat
sampl
evalu
histolog
determin
degre
fibrosi
fibrosi
stage
use
scheme
normal
minim
mild
moder
sever
serum
piiinp
concentr
measur
use
commerci
avail
ria
uniq
piiinp
ria
orion
diagnostica
data
test
normal
differ
piiinp
concentr
group
dog
analys
use
test
appropri
signific
set
p
median
serum
piiinp
concentr
dog
liver
diseas
healthi
dog
respect
p
median
serum
piiinp
concentr
dog
chronic
hepat
hepat
neoplasia
congenit
portosystem
shunt
hepatobiliari
diseas
respect
p
median
serum
piiinp
concentr
dog
mild
hepat
fibrosi
n
dog
moder
sever
hepat
fibrosi
n
respect
p
contrari
expect
serum
piiinp
concentr
significantli
higher
healthi
dog
dog
liver
diseas
signific
differ
serum
piiinp
concentr
dog
mild
dog
moder
sever
hepat
fibrosi
result
studi
support
util
serum
piiinp
biomark
canin
hepat
fibrosi
conflict
interest
conflict
interest
report
dj
roslin
institut
r
sv
edinburgh
unit
regen
medicin
edinburgh
unit
kingdom
suppli
function
canin
hepatocyt
would
invalu
resourc
drug
toxicolog
test
hepatocyt
function
declin
precipit
renew
suppli
stem
cell
attract
option
report
mesenchym
stem
cell
msc
hepatocyt
differenti
report
varieti
speci
includ
one
report
hepat
differenti
canin
amniot
msc
show
gene
express
albumin
tyrosin
aminotransferas
antiproteinas
hepatocyt
differenti
msc
wide
avail
sourc
adipos
tissu
bone
marrow
would
use
canin
adipos
bone
msc
characteris
abil
adher
plastic
differenti
osteocyt
adipocyt
chondrocyt
demonstr
posit
alizarin
red
oil
red
toludin
blue
stain
msc
type
shown
express
cell
surfac
marker
lack
express
three
stage
hepatocyt
differenti
protocol
consist
dmem
egf
bfgf
hour
hgf
nicotinamid
bfgf
day
final
hepatocyt
cultur
media
lonza
oncostatin
dexamethason
dmso
day
time
point
day
use
gene
express
function
characterist
pa
stain
glycogen
storag
indocyanin
green
icg
uptak
cytochrom
cyp
activ
canin
primari
hepatocyt
use
posit
control
differenti
protocol
cell
morpholog
chang
dramat
polygon
cell
larg
amount
cytoplasm
faint
pa
stain
icg
uptakeexcret
demonstr
day
cyp
activ
found
time
point
use
pcr
evid
hepatocyt
gene
express
demonstr
length
protocol
use
protocol
evid
induct
canin
adipos
bone
msc
demonstr
altern
method
hepatocyt
product
explor
conflict
interest
conflict
interest
report
dj
roslin
institut
r
sv
edinburgh
unit
regen
medicin
edinburgh
unit
kingdom
demonstr
stem
cell
differenti
cell
requir
batteri
function
test
one
function
test
frequent
use
uptak
fluoresc
label
ldl
label
nativ
ldl
commerci
avail
cultur
murin
human
fibroblast
report
internalis
report
taken
macrophag
endotheli
cell
hepatocyt
poss
specif
ldl
receptor
fail
recognis
acetyl
ligand
despit
paper
describ
hepatocyt
differenti
stem
cell
variou
speci
use
two
compound
almost
equal
frequenc
studi
design
investig
ldl
uptak
canin
primari
hepatocyt
assess
compound
utilis
demonstr
canin
qualiti
undifferenti
canin
adipos
bone
msc
also
test
canin
primari
hepatocyt
cultur
three
dog
euthanas
behaviour
reason
use
wedg
perfus
method
adipos
bone
msc
also
cultur
two
dog
hour
cultur
cell
incub
media
contain
hour
well
wash
three
time
fix
formaldehyd
nuclear
counterstain
perform
dapi
well
examin
lipid
uptak
use
fluoresc
microscopi
three
canin
primari
hepatocyt
cultur
demonstr
strong
uptak
sporad
cell
show
uptak
undifferenti
adipos
bone
marrow
mesenchym
stem
cell
contain
result
show
lipoprotein
uptak
demonstr
canin
properti
stem
cell
differenti
document
uptak
requir
spars
uptak
hepatocyt
cultur
like
contamin
kupffer
andor
endotheli
cell
furthermor
canin
adipos
bone
msc
show
strong
uptak
undifferenti
state
prevent
use
test
canin
msc
hepatocyt
differenti
protocol
conflict
interest
conflict
interest
report
e
e
hp
mm
n
c
helsinki
helsinki
finland
canin
idiopath
pulmonari
fibrosi
canin
ipf
progress
interstiti
lung
diseas
unknown
aetiolog
pathophysiolog
mainli
describ
old
west
highland
white
terrier
whwt
proinflammatori
chemokin
probabl
involv
pathogenesi
human
ipf
appear
diagnost
prognost
biomark
serum
balf
dog
littl
know
role
pathogenesi
ipf
recent
increas
gene
express
shown
lung
tissu
ipf
whwt
compar
control
dog
breed
aim
present
studi
compar
serum
level
healthi
whwt
versu
whwt
ipf
healthi
dog
terrier
breed
whwt
breed
ten
whwt
ipf
mean
age
year
rang
healthi
dog
includ
whwt
scottish
terrier
jack
russel
terrier
maltes
cavali
king
charl
spaniel
labrador
retriev
malinoi
belgian
shepherd
enter
studi
health
statu
base
clinic
examin
serum
biochemistri
haematolog
well
comput
tomographi
whwt
ipf
confirm
histopatholog
serum
concentr
determin
elisa
canin
quantikin
elisa
kit
r
system
result
ipf
healthi
whwt
healthi
dog
differ
breed
compar
use
global
linear
model
softwar
incorpor
effect
covari
age
gender
p
chosen
level
signific
serum
concentr
express
pgml
given
lsmean
standard
error
differ
serum
level
detect
whwt
ipf
healthi
whwt
howev
serum
concentr
significantli
higher
healthi
whwt
compar
group
healthi
dog
moreov
serum
concentr
higher
scottish
terrier
maltes
cavali
king
charl
spaniel
lowest
concentr
found
result
present
studi
show
serum
concentr
high
healthi
ipf
whwt
compar
healthi
dog
breed
therefor
use
serum
diagnost
biomark
ipf
might
relat
breed
predisposit
whwt
ipf
conflict
interest
conflict
interest
report
e
hp
mm
mj
p
c
veterinari
medicin
univers
equin
small
anim
medicin
faculti
veterinari
medicin
helsinki
medicin
divis
pulmonari
medicin
univers
helsinki
helsinki
veterinari
scienc
univers
bristol
bristol
unit
de
libr
de
bruxel
bruxel
belgium
aetiolog
pathogenesi
canin
idiopath
pulmonari
fibrosi
ipf
poorli
understood
genet
basi
suspect
predisposit
west
highland
white
terrier
whwt
previou
studi
show
serum
concentr
profibrot
protein
transform
growth
factor
beta
elev
healthi
whwt
whwt
ipf
activ
pathway
modifi
ipf
lung
present
studi
compar
express
local
protein
involv
signal
tgf
receptor
type
tbri
intracellular
messeng
phosphoryl
protein
lung
healthi
dog
dog
ipf
section
lung
tissu
obtain
ten
whwt
ipf
six
control
dog
variou
breed
primari
rabbit
antibodi
use
allow
detect
tbri
bound
antibodi
visual
use
diaminobenzidin
qualit
assess
made
compar
localis
intens
label
primari
antibodi
lung
group
dog
section
control
dog
strong
diffus
label
seen
layer
fibrou
connect
tissu
surround
bronchi
bronchiol
weaker
granular
express
seen
bronchial
vascular
smooth
muscl
contrast
bronchial
bronchiolar
epitheli
cell
distinct
apic
express
weak
granular
label
smooth
muscl
express
within
layer
fibrou
connect
tissu
ipf
lung
section
pattern
immunoreact
observ
antibodi
tissu
surround
bronchi
bronchiol
area
pulmonari
fibrosi
strong
diffus
express
fibrou
matrix
contrast
tbri
visibl
within
fibrot
tissu
strong
label
individu
alveolar
epitheli
cell
particularli
within
hyperplast
pneumocyt
alveolar
macrophag
also
appear
express
nuclear
label
observ
group
ipf
lung
intens
posit
nuclear
label
observ
alter
alveolar
epitheli
cell
ipf
lung
intens
label
fibrou
matrix
consist
high
amount
fibrot
area
increas
extracellular
storag
hyperplast
pneumocyt
appear
import
target
canin
ipf
find
intens
nuclear
label
alveolar
epithelium
confirm
activ
signal
affect
lung
tissu
conflict
interest
conflict
interest
report
e
e
hp
mm
f
n
c
veterinari
medicin
univers
equin
small
anim
medicin
faculti
veterinari
medicin
helsinki
finland
idiopath
pulmonari
fibrosi
ipf
dog
emerg
chronic
progress
interstiti
lung
diseas
unknown
aetiolog
character
irrevers
scar
lung
mainli
occur
west
highland
white
terrier
whwt
like
human
ipf
unrespons
current
therapi
basic
mechan
underli
pathogenesi
remain
unknown
among
mani
factor
growth
factor
cytokin
chemokin
involv
pathogenesi
ipf
human
role
serotonin
current
investig
aim
present
studi
determin
serum
level
dog
ipf
versu
healthi
dog
dog
chronic
pulmonari
diseas
evalu
lung
express
protein
involv
signal
receptor
type
type
transport
serum
sampl
collect
dog
ipf
whwt
scottish
terrier
yorkshir
terrier
mean
age
year
dog
chronic
bronchiti
cb
variou
breed
year
dog
eosinophil
bronchopneumopathi
ebp
variou
breed
year
healthi
whwt
year
serum
concentr
determin
elisa
group
influenc
serum
concentr
analyz
covari
analysi
anova
total
rna
extract
lung
tissu
dog
ipf
whwt
scottish
terrier
lhassa
apso
mean
age
year
control
dog
variou
breed
year
express
measur
gene
rel
copi
number
calcul
sampl
result
normal
use
two
stabli
express
housekeep
gene
tbp
lung
express
level
two
group
compar
use
student
rank
sum
test
serum
concentr
ipf
dog
statist
differ
healthi
whwt
dog
cb
ebp
express
gene
statist
differ
ipf
control
lung
tissu
result
present
studi
exclud
potenti
blood
biomark
canin
ipf
favour
major
implic
pathway
pathogenesi
canin
ipf
conflict
interest
conflict
interest
report
lio
hp
laurila
ak
lappalainen
p
mm
univers
helsinki
helsinki
finland
object
evalu
exercis
toler
west
highland
white
terrier
whwt
idiopath
pulmonari
fibrosi
ipf
use
walk
test
describ
chang
chosen
paramet
diseas
progress
ipf
whwt
median
time
rang
month
control
regularli
death
studi
endpoint
healthi
whwt
recruit
dog
walk
along
straight
corridor
pace
minut
distanc
cover
heart
rate
hr
bodi
temperatur
oxygen
satur
arteri
blood
gase
measur
nonparametr
statist
use
result
chang
clinic
paramet
initi
last
avail
measur
ipf
whwt
walk
shorter
distanc
median
rang
control
median
p
arteri
partial
pressur
oxygen
diseas
dog
seem
moder
posit
correl
p
significantli
higher
ipf
whwt
p
diseas
cours
chang
note
bodi
weight
p
hematocrit
p
sever
bronchointerstiti
radiograph
pattern
initi
classifi
moder
sever
vari
either
direct
declin
trend
valu
increas
oxygen
gradient
detect
signific
whwt
die
caus
p
prove
test
evalu
exercis
toler
ipf
whwt
could
serv
noninvas
paramet
evalu
lung
function
diseas
addit
accur
conflict
interest
conflict
interest
report
hp
lio
ak
p
e
c
mm
veterinari
medicin
univers
helsinki
helsinki
equin
small
anim
medicin
faculti
veterinari
medicin
univers
helsinki
basic
veterinari
scienc
faculti
veterinari
medicin
univers
helsinki
clinic
scienc
faculti
veterinari
medicin
univers
belgium
idiopath
pulmonari
fibrosi
ipf
incur
interstiti
lung
diseas
affect
mainli
older
west
highland
white
terrier
whwt
effect
lifespan
unclear
object
evalu
surviv
prognost
factor
whwt
ipfw
conduct
prospect
studi
year
recruit
privat
own
whwt
ipf
healthi
control
ipf
confirm
histopatholog
comput
tomographi
hrct
descript
statist
km
surviv
curv
cox
proport
hazard
ratio
perform
surviv
analysi
chosen
potenti
prognost
factor
predict
surviv
arteri
partial
pressur
oxygen
carbon
dioxid
oxygen
gradient
serum
concentr
sever
chang
thorac
radiograph
hrct
hounsfield
unit
valu
complet
blood
cell
count
valu
km
curv
analysi
logist
regress
model
use
prognost
factor
analysisth
median
surviv
deceas
whwt
ipf
onset
symptom
month
rang
month
median
surviv
month
rang
month
risk
death
whwt
ipf
significantli
higher
hazard
ratio
confid
interv
p
control
whwt
signific
prognost
factor
identifi
four
five
dog
euthan
due
acut
dyspnea
diffus
alveolar
damag
lungsipf
neg
impact
life
expect
whwt
individu
surviv
vari
consider
ipf
whwt
may
therefor
rapid
slowli
progress
diseas
cours
like
human
ipf
conflict
interest
conflict
interest
report
canonn
f
billen
c
clercx
faculti
veterinari
medicin
univers
belgium
belgium
classic
treatment
dog
idiopath
eosinophil
bronchopneumopathi
ebp
consist
oral
administr
prednisolon
minimum
effect
dose
unfortun
chronic
system
glucocorticosteroid
therapi
may
lead
iatrogen
hyperadrenocortic
therefor
altern
treatment
inhal
steroid
administr
increasingli
use
although
clinic
respons
therapi
evalu
dog
ebp
aim
studi
assess
clinic
respons
inhal
steroid
therapi
fluticason
ist
investig
possibl
side
effect
includ
inhibit
axi
paa
six
dog
ebp
whippet
brittani
spaniel
border
terrier
huski
femal
male
median
age
month
diagnos
base
clinic
blood
radiograph
bronchoscop
examin
bronchoalveolar
lavag
fluid
analysi
treat
ist
month
retrospect
recruit
time
diagnosi
durat
clinic
sign
vari
month
median
clinic
sever
index
csi
assign
base
clinic
sign
cough
retch
exercis
intoler
calcul
vari
time
recheck
median
month
week
year
csi
calcul
acth
stimul
test
perform
fluticason
dosag
vari
bid
csi
decreas
dog
vari
three
dog
show
persist
cough
medic
week
dog
daili
one
dog
cough
reappear
soon
treatment
regularli
administ
two
dog
treat
ist
year
acth
stimul
test
reveal
inhibit
paa
one
dog
overt
clinic
sign
iatrogen
hyperadrenocortic
preliminari
studi
indic
treatment
ebp
long
term
ist
appear
allow
proper
manag
affect
dog
besid
long
term
ist
may
induc
inhibit
paa
prospect
studi
includ
higher
number
dog
treat
ist
regular
control
paa
warrant
conflict
interest
conflict
interest
report
sj
viitanen
hp
laurila
lio
melami
mm
univers
helsinki
faculti
veterinari
medicin
univers
helsinki
finland
protein
crp
major
acut
phase
protein
low
serum
concentr
healthi
dog
rise
rapidli
inflamm
aim
studi
investig
crp
level
variou
canin
respiratori
diseas
examin
whether
crp
use
biomark
diagnost
pneumonia
prospect
observ
studi
conduct
studi
popul
dog
differ
respiratori
diseas
bacteri
pneumonia
bp
primari
bacteri
tracheobronch
pbtb
eosinophil
bronchopneumopathi
ebp
chronic
bronchiti
cb
idiopath
pulmonari
fibrosi
ipf
cardiogen
pulmonari
edema
cpe
collect
diagnosi
confirm
dog
thorough
clinic
examin
addit
bronchoalveolar
lavag
histopatholog
healthi
blood
donor
dog
includ
control
crp
measur
use
quantit
immunoassay
canin
crp
test
kit
differ
group
crp
evalu
analysi
varianc
model
anova
dog
bp
significantli
higher
serum
crp
concentr
median
mgl
interquartil
rang
mgl
compar
dog
pbtb
p
cb
p
ebp
p
ipf
p
cpe
p
healthi
control
p
dog
pbtb
significantli
higher
crp
compar
dog
cb
p
ebp
p
healthi
control
p
result
indic
crp
potenti
use
addit
biomark
especi
diagnost
bacteri
pneumonia
conflict
interest
conflict
interest
report
km
biermann
r
mischk
univers
hannov
hannov
germani
clopidogrel
potent
platelet
inhibitor
wide
use
human
increas
relev
dog
cat
aim
studi
assess
platelet
function
healthi
dog
treat
three
differ
dose
clopidogrel
use
differ
method
evalu
platelet
function
eighteen
healthi
dog
differ
breed
divid
equal
group
treat
oral
mgkg
clopidogrel
group
mgkg
group
mgkg
group
day
blood
sampl
perform
treatment
day
platelet
function
assess
use
imped
aggregomet
three
differ
agonist
collagen
col
adenosin
diphosph
adp
aspirin
aspi
addit
test
primari
hemostasi
includ
platelet
count
capillari
bleed
time
autom
platelet
function
analys
turbidimetr
aggreg
data
analys
anova
repeat
measur
subsequ
anova
individu
group
follow
indic
alpha
set
anova
reveal
signific
chang
time
imped
aggregometri
area
curv
auc
valu
capillari
bleed
time
closur
time
measur
pfa
collagenadp
cartridg
signific
differ
dosag
group
demonstr
capillari
bleed
time
imped
aggregometri
imped
aggregometri
decreas
significantli
start
day
group
day
group
imped
aggregometri
closur
time
pfa
collagenadp
cartridg
show
tendenc
toward
lower
valu
group
receiv
higher
dosag
group
capillari
bleed
time
increas
significantli
compar
baselin
conclus
result
studi
reveal
limit
effect
low
dosag
mgkg
clopidogrel
platelet
function
test
dog
howev
higher
dosag
least
mgkg
seem
necessari
significantli
inhibit
platelet
function
clinic
use
conflict
interest
conflict
interest
report
f
bolognaclinica
veterinaria
san
marco
padova
bologna
bologna
marco
veterinari
clinic
padua
itali
intox
anticoagul
rodenticid
may
caus
haemorrhag
diathesi
dog
inform
avail
long
clot
time
take
normalis
vitamin
k
treatment
literatur
suggest
intraven
iv
vitamin
k
administr
may
caus
anaphylaxi
refer
statement
provid
aim
studi
evalu
time
normalis
activ
partial
thromboplastin
time
appt
prothrombin
time
pt
intraven
vitamin
k
treatment
dog
natur
anticoagul
rodenticid
ar
intox
inclus
criteria
ar
intox
detect
intern
extern
bleed
prolong
coagul
time
consist
ar
intox
exclus
reason
clinic
bleed
complet
clinic
record
coagul
profil
pt
aptt
antithrombin
fibrinogen
fdp
concentr
collect
present
vitamin
k
administ
mgkg
intraven
minut
protect
light
four
hour
hour
k
administr
coagul
profil
repeat
dog
ar
poison
refer
san
marco
veterinari
clinic
met
inclus
criteria
aptt
pt
valu
compar
repeat
measur
analysi
varianc
friedman
test
respect
dog
pt
aptt
within
refer
rang
second
second
respect
mean
appt
median
pt
second
respect
mean
appt
median
pt
second
respect
data
avail
dog
mean
appt
median
pt
second
respect
signific
decreas
aptt
pt
p
comparison
dog
surviv
discharg
none
receiv
blood
plasma
transfus
advers
reaction
vitamin
k
iv
supplement
dog
show
clinic
sign
ongo
extern
bleed
protocol
vitamin
k
administr
seem
safe
effect
treatment
dog
natur
occur
ar
intox
conflict
interest
conflict
interest
report
sl
r
liverpool
neston
unit
north
mymm
unit
cosham
veterinari
clinic
horsham
unit
kingdom
trap
neutrophil
syndrom
tn
autosom
recess
condit
report
border
colli
characteris
reduc
circul
neutrophil
number
intramedullari
myeloid
hyperplasia
affect
dog
present
fever
neutropenia
failur
thrive
young
age
tn
origin
identifi
dog
australia
new
zealand
report
japan
clinic
report
tn
unit
kingdom
although
activ
screen
programm
report
carrier
rate
although
border
colli
breed
known
affect
cyclic
neutropenia
grey
colli
syndrom
veterinarian
may
familiar
tn
manag
prognosi
differ
object
studi
report
present
manag
three
unrel
dog
uk
confirm
tn
three
black
white
border
colli
puppi
present
assess
pyrexia
musculoskelet
sign
three
dog
pyrex
present
least
one
grossli
swollen
pain
joint
small
statur
facial
dysmorph
typic
tn
elong
narrow
facial
featur
cbc
reveal
neutropenia
neutrophil
count
ri
biochemistri
mostli
normal
serum
cobalamin
normal
bone
marrow
aspir
two
case
reveal
expans
myeloid
seri
arthrocentesi
consist
polyarthr
genet
test
pcr
confirm
three
puppi
homozyg
mutat
caus
tn
carri
mutat
caus
cyclic
neutropenia
dog
initi
treat
intraven
fluid
therapi
antibiot
signific
improv
subsequ
receiv
prednisolon
immunosuppress
dose
mark
improv
mentat
ambul
observ
within
hour
three
case
one
prednisolon
taper
withdrawn
dog
remain
clinic
stabl
month
initi
present
case
two
prednisolon
taper
discontinu
one
year
dog
remain
clinic
well
month
despit
intermitt
episod
inappet
pyrexia
case
three
prednisolon
antibiot
continu
indefinit
patient
surviv
month
tn
differenti
diagnosi
uk
border
colli
neutropenia
studi
support
previou
australian
studi
describ
success
medic
manag
condit
although
prognosi
remain
guard
owner
must
counsel
regard
requir
medic
occasion
hospitalis
conflict
interest
primari
author
resid
partial
fund
bsava
petsav
fjw
k
ac
j
de
van
lieg
lieg
citadel
lieg
belgium
use
omeprazol
inhibitor
advoc
dog
reduc
cerebrospin
fluid
csf
product
condit
accumul
csf
may
associ
intracrani
hypertens
hydrocephalu
syringomyelia
two
previou
studi
shown
signific
reduct
csf
product
follow
ventriculocistern
intraven
administr
omeprazol
dog
rabbit
howev
underli
mechan
remain
undetermin
prior
work
human
suggest
albumin
quotient
qalb
ratio
csf
serum
albumin
concentr
best
paramet
evalu
csf
flow
decreas
csf
product
result
increas
qalb
present
studi
evalu
impact
omeprazol
administr
canin
blood
csf
composit
includ
qalb
fifteen
healthi
experiment
beagl
dog
receiv
omeprazol
mgkgday
oral
day
dog
ml
csf
collect
cistern
ml
blood
obtain
jugular
vein
treatment
albumin
concentr
evalu
immunoturbidimetr
assay
gold
standard
human
medicin
protein
electrophoresi
hre
pair
csf
serum
sampl
accord
guidelin
intern
consensu
group
csf
analysi
erythrocyt
leukocyt
count
ph
lactat
glucos
total
protein
electrolyt
concentr
also
measur
signific
differ
composit
csf
omeprazol
administr
except
mild
increas
sodium
p
strong
linear
correl
found
albumin
concentr
measur
immunoturbidimetri
hre
p
correl
coeffici
regardless
methodolog
qalb
chang
significantli
p
omeprazol
induc
statist
signific
increas
venou
ph
p
lack
chang
qalb
present
studi
suggest
chang
csf
flow
follow
oral
therapi
omeprazol
contradict
previou
studi
detect
reduc
csf
flow
shortli
administr
therefor
present
studi
provid
evid
scientif
benefit
omeprazol
treatment
reduc
csf
product
dog
research
warrant
explain
find
conflict
interest
conflict
interest
report
n
g
school
veterinari
medicin
hebrew
univers
jerusalem
rehovot
veterinari
institut
depart
bacteriolog
israel
acinetobact
baumannii
acb
strictli
aerob
nosocomi
pathogen
coccobacillu
respons
fatal
pneumonia
infect
outbreak
human
mortal
rate
highli
resist
major
antimicrobi
dri
environ
disinfect
acb
infect
increasingli
report
dog
cat
report
describ
sever
nosocomi
outbreak
multidrug
resist
mdr
acb
isol
induc
system
highli
fatal
ill
veterinari
hospit
occur
sever
cluster
affect
dog
cat
microbiolog
posit
isol
acb
isol
urin
anim
respiratori
tract
tissu
blood
common
underli
primari
diagnos
includ
seizur
variou
caus
anim
pneumonia
lung
contus
lymphoma
acut
lung
injuri
felin
idiopath
cystiti
heatstrok
urinari
tract
infect
uti
intervertebr
disk
herniat
overal
mortal
rate
anim
acb
infect
play
major
part
mortal
anim
contribut
mortal
clinic
laboratori
sign
includ
fever
tracheal
tube
purul
discharg
hypotens
neutropenia
neutrophilia
neutrophil
cytoplasm
toxic
absent
previous
hospit
acb
associ
infect
includ
pneumonia
uti
cellul
sepsi
infect
anim
hospit
intens
care
unit
icu
howev
infect
identifi
anim
ward
includ
one
dog
hospit
isol
mortal
unassoci
hospit
length
urinari
cathet
placement
tracheal
intub
ventil
mortal
rate
tend
increas
p
respiratori
acb
infect
compar
organ
infect
isol
acb
resist
numer
antibiot
exclud
amikacin
imipenem
ticarcillin
outbreak
environment
investig
perform
sampl
cage
rail
phone
sink
ventil
obtain
yield
pure
acb
cultur
isol
ident
mdr
profil
determin
acb
isol
infect
anim
infect
control
protocol
implement
includ
aggress
disinfect
surfac
equip
staff
educ
regard
person
hygien
antisepsi
subsequ
led
sharp
decreas
incid
mdr
acb
infect
hospit
outbreak
mdr
acb
infect
may
highli
fatal
difficult
irradi
warrant
educ
antisept
techniqu
judici
antibiot
use
especi
veterinari
icu
conflict
interest
conflict
interest
report
r
univers
murdoch
perth
sturt
univers
wagga
wagga
anim
specialist
hospit
sydney
specialist
servic
brisban
sydney
sydney
australia
cryptococcosi
affect
cat
dog
worldwid
predilect
respiratori
tract
common
cat
dog
abdomin
cryptococcosi
rare
cat
dog
peopl
common
ferret
hors
databas
four
referr
centr
three
veterinari
laboratori
search
cryptococcosi
primarili
affect
structur
signal
clinic
find
antigen
titr
cultur
treatment
outcom
review
case
dog
one
cat
met
inclus
criteria
median
age
weight
diagnosi
dog
year
year
kg
kg
respect
breed
includ
staffordshir
bull
terrier
bulldog
seven
purebr
crossbr
male
castrat
femal
spay
cat
male
neuter
domest
shorthair
major
case
western
australia
four
queensland
one
victoria
new
south
wale
south
australia
present
complaint
includ
inappet
lethargi
vomit
hematemesi
diarrhoea
melaena
dyschezia
weight
loss
mass
note
owner
physic
find
includ
fever
abdomin
distens
pain
abdomin
mass
effus
ataxiaback
pain
cryptococc
lesion
involv
stomach
small
larg
bowel
ileocaecocol
junction
abdomin
cavitymesenteri
kidney
liver
pancrea
eight
case
thorac
imag
three
lesion
antigen
titr
rang
median
dog
test
cultur
attempt
eight
patient
yield
cgattii
cneoforman
one
case
fail
grow
vitro
untreat
case
euthanas
diagnosi
treatment
attempt
patient
consist
complet
surgic
excis
surgic
excis
plu
therapi
therapi
alon
median
surviv
treat
patient
day
surviv
two
case
treat
surgeri
alon
day
median
surviv
medic
treat
case
day
combin
therapi
day
abdomin
cryptococcosi
infect
much
common
dog
cat
success
therapi
requir
aggress
manag
hypothesis
scaveng
natur
dog
predispos
transient
intestin
colonis
mucos
injuri
permit
invas
gut
wall
subsequ
spread
contigu
structur
andor
dissemin
via
lymphat
portal
venou
pathway
conflict
interest
conflict
interest
report
r
e
k
g
univers
veterinari
teach
hospit
rehovot
san
marco
padoa
itali
spirocerca
lupi
infect
dog
typic
result
esophag
nodul
malign
esophag
nodul
transform
sarcoma
occur
case
definit
ant
mortem
discrimin
benign
malign
esophag
mass
difficult
requir
endoscopi
histopatholog
esophag
biopsi
microscop
examin
esophag
specimen
serum
acut
phase
protein
app
concentr
dog
chang
respons
inflamm
util
diagnost
prognost
marker
variou
canin
diseas
studi
aim
character
serum
app
concentr
dog
esophag
spirocercosi
investig
discriminatori
perform
malign
benign
esophag
nodul
studi
includ
dog
esophag
spirocercosi
therapi
serum
protein
crp
haptoglobin
hp
saa
albumin
concentr
measur
present
visit
compar
healthi
dog
malign
benign
esophag
spirocercosi
case
receiv
oper
characterist
roc
analys
use
assess
diagnost
util
app
white
blood
cell
count
wbc
discrimin
malign
benign
case
serum
hp
crp
saa
concentr
present
visit
significantli
higher
albumin
concentr
significantli
lower
infect
dog
compar
refer
interv
ri
p
chang
significantli
anthelmint
therapi
compar
benign
case
neoplast
case
significantli
higher
level
crp
p
hp
p
saa
p
albumin
concentr
significantli
lower
p
howev
serum
concentr
app
leukocyt
count
moder
discrimin
suspect
neoplast
benign
esophag
nodul
area
roc
curv
respect
nevertheless
neoplast
case
concentr
four
app
within
refer
interv
concurr
conclus
canin
esophag
spirocercosi
character
acut
phase
reaction
present
anthelmint
therapi
use
monitor
respons
treatment
concentr
four
within
ri
esophag
malign
rule
although
concentr
posit
app
significantli
higher
neoplast
compar
benign
case
moder
discriminatori
power
preclud
individu
clinic
use
spirocercosi
conflict
interest
conflict
interest
report
jr
al
v
pa
rk
k
small
anim
intern
medicin
munich
mycolog
institut
infecti
diseas
zoonos
munich
med
labor
gmbh
divis
idexx
laboratori
ludwigsburg
germani
leptospirosi
zoonot
diseas
among
human
dog
worldwid
role
healthi
dog
sourc
infect
unknown
thu
aim
studi
evalu
number
healthi
dog
shed
leptospir
urin
identifi
genomospeci
leptospir
second
aim
antibodi
preval
evalu
urin
sampl
healthi
dog
southern
germani
prospect
includ
studi
evalu
quantit
polymeras
chain
reaction
pcr
specif
gene
leptospira
l
spp
posit
sampl
test
via
multilocu
sequenc
type
mlst
identifi
genomospeci
microscop
agglutin
test
mat
perform
determin
antibodi
titer
three
urin
sampl
leptospir
indic
preval
urinari
shed
confid
interv
three
dog
vaccin
old
vaccin
contain
two
serovar
one
dog
shed
leptospir
genomospeci
l
interrogan
two
genomospeci
l
borgpetersenii
dog
confid
interv
antibodi
titer
serogroup
confid
interv
titer
healthi
dog
southern
germani
shed
leptospir
pathogen
genomospeci
dog
repres
potenti
risk
owner
anim
studi
emphas
import
use
vaccin
contain
broader
rang
serovar
protect
diseas
also
prevent
shed
conflict
interest
conflict
interest
report
k
b
rs
c
u
k
small
anim
medicin
munich
munichclin
rumin
herd
manag
munich
leipziginstitut
anim
hygien
veterinari
public
health
leipzig
germani
felin
panleukopenia
fpv
frequent
commonli
fatal
diseas
cat
recent
publish
studi
rais
suspicion
cat
fail
develop
antibodi
vaccin
purpos
studi
assess
preval
antibodi
fpv
cat
southern
germani
identifi
factor
associ
lack
antibodi
three
hundr
fifti
cat
blood
taken
variou
unrel
reason
eg
health
check
test
felin
retroviru
infect
diffent
clinic
sign
randomli
includ
studi
prior
power
analysi
determin
minimum
number
cat
includ
inform
regard
signal
origin
environ
lifestyl
hous
condit
health
statu
chronic
diseas
glucocorticoid
therapi
vaccin
statu
collect
antibodi
detect
hemagglutin
inhibit
test
asymptomat
test
univari
logist
regress
use
investig
associ
lack
antibodi
paramet
obtain
signal
histori
paramet
determin
statist
signific
verifi
multivari
logist
regress
analysi
one
hundr
three
cat
antibodi
even
properli
vaccin
cat
antibodi
detect
chronic
kidney
diseas
neoplasia
glucocorticoid
therapi
vaccin
statu
significantli
associ
lack
antibodi
studi
nearli
one
third
cat
antibodi
like
inadequ
immun
panleukopenia
cat
chronic
diseas
cat
receiv
glucocorticoid
protect
less
frequent
conflict
interest
conflict
interest
report
c
c
c
b
canin
aimargu
ecol
national
dalfort
toulous
toulousain
delevag
et
reproduct
uter
umr
inraenvt
ihap
toulous
franc
introduct
puppi
wean
diarrhea
frequent
diseas
deleteri
consequ
growth
recent
fecal
score
scale
puppi
develop
provid
object
definit
abnorm
fecal
score
rather
due
one
pathogen
wean
diarrhea
result
interact
infecti
agent
host
immun
manag
procedur
aim
studi
identifi
risk
factor
patholog
fece
puppi
french
breed
kennel
materi
method
french
breed
kennel
includ
kennel
data
environment
factor
size
kennel
number
puppi
litter
manag
kennel
puppi
number
meal
per
day
clean
disinfect
procedur
access
outdoor
number
person
dedic
puppi
puppi
characterist
age
breed
sex
collect
stool
qualiti
score
puppi
parasit
excret
evalu
mcmaster
flotat
techniqu
presenc
giardia
intestinali
cryptosporidium
parvum
evalu
micropl
assay
remel
lenexa
ks
usa
canin
parvoviru
type
canin
coronaviru
ccv
excret
evalu
respect
qpcr
sever
separ
univari
three
binari
logist
regress
model
sa
softwar
use
evalu
factor
influenc
fece
qualiti
result
puppi
week
age
includ
puppi
hous
breed
kennel
produc
puppi
per
year
preval
enteropathogen
giardia
sp
ccv
isospora
ohioensi
complex
c
parvum
toxocara
cani
isospora
cani
fece
evalu
classifi
abnorm
among
enteropathogen
uniqu
pathogen
associ
patholog
fecal
score
among
environment
factor
number
puppi
produc
per
year
kennel
number
meal
per
day
two
factor
impact
fece
qualiti
final
model
includ
enteropathogen
environment
factor
uniqu
factor
signific
impact
conclus
studi
underlin
high
preval
enteropathogen
puppi
circul
need
suspect
case
wean
diarrhea
even
absenc
typic
clinic
sign
mortal
grellet
et
al
prev
vet
med
conflict
interest
employ
royal
canin
k
geisweid
k
weber
c
k
hartmann
lmu
univers
munich
munich
germani
due
increas
number
dog
import
visit
mediterranean
countri
canin
leishmaniasi
becom
import
infecti
diseas
germani
although
conjunctiv
swab
recent
describ
use
diagnost
tool
endem
area
valu
area
unknown
aim
studi
evalu
sensit
specif
conjunctiv
swab
polymeras
chain
reaction
pcr
dog
area
seventi
four
dog
present
suspect
canin
leishmaniasi
screen
purpos
travel
endem
countri
prospect
includ
pcr
result
conjuctiv
swab
compar
bone
marrow
lymph
node
blood
antibodi
result
determin
immunofluoresc
assay
immunosorb
assay
dog
consid
infect
bone
marrow
andor
lymph
node
andor
blood
pcr
posit
defin
infect
bone
marrow
pcr
consid
test
highest
sensit
neg
sensit
specif
conjunctiv
swab
pcr
ci
ci
substanti
agreement
pcr
result
conjunctiv
swab
lymph
node
fair
moder
agreement
conjuncitv
swab
bone
marrow
almost
agreement
conjunctiv
swab
blood
conjunctiv
swab
pcr
good
test
diagnos
leishmania
infect
dog
countri
conflict
interest
conflict
interest
report
k
b
u
k
small
anim
medicin
munich
leipziginstitut
anim
hygien
veterinari
public
health
leipzig
munichclin
rumin
herd
manag
munich
germani
routin
titer
test
determin
specif
immun
statu
instead
regular
vaccin
establish
european
countri
far
test
detect
antibodi
felin
panleukopenia
viru
fpv
felin
vaccicheck
avail
sever
european
countri
aim
studi
evalu
perform
test
felin
vaccicheck
comparison
gold
standard
hemagglutin
inhibit
hi
serum
sampl
randomli
select
cat
n
obtain
unrel
reason
includ
hi
use
gold
standard
antibodi
detect
sensit
specif
posit
neg
predict
valu
overal
accuraci
felin
vaccicheck
assess
kappa
use
assess
agreement
differ
method
preval
antibodi
detect
hi
felin
vaccicheck
show
sensit
specif
base
antibodi
preval
posit
predict
valu
neg
predict
valu
overal
accuraci
test
kappa
standard
error
se
confid
interv
ci
intend
use
test
replac
regular
booster
vaccin
veterinari
practic
low
number
fals
posit
test
result
import
thu
specif
test
present
studi
good
enough
therefor
test
fulli
recommend
replac
vaccin
especi
cat
risk
conflict
interest
biogal
gale
laboratori
kibbutz
gale
israel
sold
test
reduc
price
studi
rao
n
mmre
l
veterinari
medicin
technic
univers
lisbon
lisbon
franc
school
hygien
tropic
medicinecentro
de
univ
lisboa
london
unit
kingdom
immunomodul
drug
often
use
felin
medicin
although
altern
oral
trial
success
appli
viral
infect
licens
protocol
recommend
felin
immunodefici
viru
fiv
infect
cat
protocol
shown
improv
clinic
sign
reduc
concurr
viral
excret
increas
level
acut
phase
protein
app
despit
effect
cost
limit
altern
protocol
requir
studi
aim
evalu
clinic
improv
natur
cat
treat
oral
protocol
per
os
daili
day
comparison
licens
one
cycl
subcutan
daili
inject
day
fiv
cat
treat
oral
protocol
po
group
cat
indoor
anim
live
environ
clinic
sign
monitor
therapi
end
therapi
use
previous
valid
score
scale
includ
relev
sign
fiv
infect
result
compar
previou
clinic
data
natur
cat
live
anim
shelter
treat
licens
protocol
sc
group
accord
group
consid
extern
posit
control
group
clinic
improv
classifi
mark
improv
initi
score
mild
improv
stabl
final
initi
score
wors
final
score
higher
initi
differ
group
proport
cat
show
improv
pearson
test
adjust
small
sampl
p
grade
clinic
improv
pearson
test
p
detail
cat
improv
overal
score
oral
therapi
specif
show
mark
improv
mild
improv
remain
stabl
sc
group
cat
improv
overal
score
particular
mark
improv
mild
improv
remain
stabl
worsen
observ
group
independ
protocol
appli
studi
show
induc
overal
signific
clinic
improv
treat
cat
support
potenti
although
licens
protocol
better
recommend
symptomat
anim
case
cost
might
issu
oral
may
consid
altern
therapi
manag
cat
conflict
interest
mcgahi
employe
virbac
carro
franc
contribut
work
mainli
consult
work
support
project
ciisa
rodolfo
leal
phd
fellow
fct
sfrh
bd
portug
solang
gil
research
assist
programa
b
c
c
r
k
small
anim
medicin
lmu
univers
munich
munich
clinic
veterinari
scienc
univers
bristol
bristol
unit
rumin
lmu
univers
munich
oberschleissheim
germani
felin
interferon
omega
use
treatment
acut
felin
upper
respiratori
tract
diseas
furtd
despit
lack
control
studi
confirm
efficaci
studi
aim
evalu
whether
local
improv
clinic
sign
cat
acut
furtd
caus
felin
caliciviru
fcv
felin
herpesviru
reduc
number
cat
shed
fcv
day
period
studi
design
prospect
random
clinic
trial
includ
cat
acut
fcv
andor
infect
clinic
sign
furtd
presenc
fcv
determin
quantit
polymeras
chain
reaction
oropharyng
conjunctiv
swab
cat
assign
either
treatment
mukg
sc
follow
mu
local
h
divid
conjunctiv
intranas
oral
placebo
day
cat
group
receiv
standard
treatment
addit
clinic
sign
fcv
shed
evalu
day
cat
group
respond
rapidli
signific
improv
gener
health
statu
nasal
ocular
discharg
clinic
laboratori
variabl
differ
among
group
intragroup
analysi
chang
time
within
group
reveal
signific
decreas
rel
fcv
copi
number
day
improv
oromucos
ulcer
day
differ
present
placebo
group
local
administr
effect
treatment
cat
acut
viral
furtd
might
lead
improv
chronic
oral
chang
immunomodulatori
mechan
conflict
interest
studi
partial
support
virbac
tierarzneimittel
gmbh
bad
oldeslo
germani
c
p
anim
vet
clinic
bonn
anim
medic
center
new
york
unit
state
america
whole
blood
taurin
wbt
concentr
measur
iw
dog
receiv
cardiovascular
examin
includ
echocardiogram
result
dcm
detect
heart
diseas
wbt
concentr
sever
reduc
nmolml
dog
dcm
without
heart
diseas
moder
low
nmolml
dcm
without
heart
diseas
time
blood
collect
preval
wbt
defici
similar
iw
without
dcm
follow
inform
avail
iw
dog
without
dcm
time
blood
sampl
collect
wbt
analysi
ten
dog
follow
year
develop
dcm
month
year
initi
examin
four
sever
reduc
wbt
one
develop
dcm
af
year
later
evid
dcm
one
healthi
year
later
die
diseas
year
later
fourth
dog
lost
follow
dog
moder
reduc
wbt
develop
af
without
dcm
develop
dcm
die
death
year
later
normal
heart
lost
follow
dog
margin
wbt
develop
dcm
af
normal
heart
lost
follow
dog
normal
wbt
develop
af
without
dcm
normal
heart
die
death
year
later
lost
follow
proport
dog
develop
dcm
af
subsequ
compar
proport
normal
heart
two
separ
categori
dog
margin
moder
sever
wbt
defici
combin
compar
dog
normal
wbt
proport
develop
dcm
af
significantli
higher
low
wbt
cohort
p
dog
wbt
defici
compar
dog
margin
normal
wbt
combin
proport
develop
dcm
af
significantli
higher
wbt
defici
cohort
p
none
dog
normal
wbt
develop
dcm
one
develop
af
conclus
studi
requir
investig
potenti
relationship
prolong
taurin
defici
myocardi
dysfunct
predisposit
develop
dcm
iw
breed
conflict
interest
taurin
measur
carri
laboratori
royal
canin
compani
h
k
n
jg
gmbh
cokg
bad
kissingen
kleintier
der
leipzig
leipzig
klinik
kleintier
kaiserberg
duisburg
germani
introduct
dil
cardiomyopathi
dcm
character
systol
dysfunct
well
ventricular
often
atrial
dilat
patholog
find
mainli
describ
dcm
doberman
pinscher
typic
histolog
find
includ
attenu
wavi
fiber
type
wtype
fatti
infiltr
degen
type
ftype
report
patholog
find
dog
giant
breed
like
great
dane
concern
heart
diseas
rare
find
materi
method
heart
great
dane
year
old
investig
clinic
gross
patholog
histopatholog
use
picrosiriu
red
stain
result
six
dog
without
heart
diseas
suffer
neoplast
diseas
pachymening
ossifican
serv
control
seven
dog
diagnos
dcm
congest
heart
failur
atrial
fibril
echocardiograph
investig
dog
show
diamet
left
ventricl
systol
dcm
cm
vs
control
cm
p
diastol
dcm
cm
vs
control
cm
p
well
dcm
vs
control
p
significantli
increas
compar
control
gross
investig
heart
dcm
show
moder
dilat
left
ventricl
flatten
papillari
muscl
contrast
echocardiographi
gross
investig
detect
significantli
thin
left
ventricular
wall
dcm
group
dcm
cm
vs
control
cm
p
rel
heart
weight
differ
group
dcm
vs
control
p
histopatholog
find
uniform
one
dog
similar
tissu
chang
doberman
pinscher
wtype
morpholog
n
diagnos
three
dog
mixtur
wtype
ftype
mainli
fibrot
lesion
seen
moder
mark
replac
fibrosi
present
right
ventricular
myocardium
n
ventricl
n
one
great
dane
show
clinic
typic
phenotyp
dcm
clinic
symptom
aggrav
next
three
year
dog
die
gastric
syndrom
patholog
investig
show
mark
left
ventricular
fibrosi
thu
diagnosi
dcm
question
retrospect
view
conclus
conclus
interdisciplinari
investig
show
great
dane
typic
clinic
gross
find
dcm
correl
vari
histopatholog
alter
histolog
find
great
dane
differ
doberman
pinscher
dcm
besid
two
known
major
patholog
chang
dcm
extend
myocardi
fibrosi
seem
predomin
alter
great
dane
conflict
interest
conflict
interest
report
ra
sb
mp
veterinaria
malpensa
samar
veterinario
portoni
rossi
zola
predosa
itali
english
bulldog
eb
affect
segment
form
arrhythmogen
right
ventricular
cardiomyopathi
arvc
characterist
dilat
right
ventricular
outflow
tract
monomorph
ventricular
tachycardia
left
bundl
branch
block
morpholog
aim
studi
evalu
arrhythmia
preval
ambulatori
electrocardiographi
eb
myocardi
disord
compar
normal
dog
breed
medic
record
eb
refer
cardiac
consult
retrospect
analyz
dog
congenit
heart
diseas
advanc
atrioventricular
block
accessori
pathway
exclud
dog
male
femal
mean
age
sd
month
mean
bodi
weight
kg
includ
studi
accord
instrument
find
admiss
dog
divid
two
group
normal
dog
dog
primari
myocardi
disord
sign
congest
normal
distribut
valu
assess
normal
distribut
data
test
use
student
distribut
data
use
wilcoxon
sum
rank
test
multivari
analysi
perform
glm
anova
test
influenc
variabl
congest
cardiac
failur
result
dog
cardiomyopathi
result
older
month
ci
vs
month
ci
p
higher
count
total
beat
ci
vs
ci
p
ectop
beat
ci
vs
ci
p
higher
averag
ventricular
rate
bpm
ci
vs
bpm
ci
p
longer
supraventricular
tachycardia
ci
vs
ci
p
lower
count
ventricular
paus
ci
vs
ci
p
sinu
bradycardia
ci
vs
ci
p
multivari
analysi
show
trend
p
higher
vpc
count
ventricular
tachycardia
run
allorhythm
form
dog
sign
congest
similarli
boxer
human
be
arvc
also
eb
affect
cardiomyopathi
character
ventricular
supraventricular
arrhythmia
high
sympathet
tone
studi
larger
sampl
need
evalu
influenc
differ
factor
expand
result
gener
popul
conflict
interest
conflict
interest
report
b
pedro
h
stephenson
c
linney
j
small
anim
teach
hospit
univers
liverpool
cheshir
unit
kingdom
dilat
cardiomyopathi
dcm
diseas
high
preval
great
dane
gd
long
occult
phase
requir
serial
echocardiographi
detect
dog
risk
strain
st
strain
rate
sr
imag
base
speckl
track
ste
method
assess
myocardi
function
advantag
tissu
doppler
assess
independ
translat
movement
inson
angl
valu
st
sr
vari
dog
differ
size
therefor
refer
interv
requir
gd
assess
echocardiograph
imag
obtain
underw
analysi
radial
circumferenti
st
sr
ste
dog
classifi
normal
norm
equivoc
equiv
affect
afx
dog
least
echocardiograph
examin
dog
signific
congenit
acquir
cardiac
system
diseas
exclud
equiv
dog
purpos
present
analysi
echocardiograph
studi
unsatisfactori
imag
qualiti
also
exclud
gd
norm
afx
norm
group
consist
fifteen
male
femal
mean
age
month
mean
weight
kg
afx
group
consist
male
fifteen
femal
mean
age
month
mean
weight
kg
fifteen
norm
dog
repeat
echocardiographi
radial
st
rst
sr
rsr
obtain
right
parastern
short
axi
view
papillari
muscl
level
dog
dog
circumferenti
st
sr
obtain
right
parastern
short
axi
view
level
mitral
valv
mvcst
mvcsr
respect
apex
apcst
apcsr
respect
dog
segment
valu
averag
obtain
global
st
sr
result
deviat
norm
afx
group
respect
differ
paramet
rst
p
rsr
systol
p
earli
diastol
p
late
diastol
p
mvcst
p
mvcsr
systol
p
earli
diastol
p
late
diastol
p
apcst
p
apcsr
systol
p
earli
diastol
p
late
diastol
p
studi
demonstr
ste
assess
radial
circumferenti
st
sr
feasibl
gd
cst
csr
appear
use
differenti
norm
afx
dog
normal
refer
interv
gd
may
allow
earli
identif
systol
dysfunct
occult
dcm
equiv
dog
conflict
interest
conflict
interest
report
mjm
dirven
dierenkliniek
rijen
rijen
netherland
studi
concern
cat
heart
diseas
relat
referr
popul
character
felin
heart
diseas
gener
practic
remain
echocardiographi
consid
method
choic
diagnos
felin
heart
diseas
echocardiograph
evid
left
atrial
enlarg
consid
poor
prognost
variabl
aim
studi
assess
rel
frequenc
differ
form
heart
diseas
encount
gener
practic
describ
presenc
left
atrial
enlarg
differ
heart
diseas
case
record
cat
underw
echocardiograph
examin
dierenkliniek
rijen
may
decemb
review
retrospect
n
referr
case
screen
n
examin
n
examin
kitten
n
exclud
case
heart
diseas
suspect
base
presenc
heart
murmur
gallop
arrhythmia
andor
dyspnea
syncop
cold
paralyz
extrem
age
rang
month
case
echocardiograph
diagnosi
heart
diseas
made
congenit
heart
diseas
cat
acquir
heart
diseas
case
concentr
left
ventricular
hypertrophi
clvh
found
case
without
dynam
left
ventricular
outflow
tract
obstruct
dlvoto
case
case
respect
isol
dlvoto
found
cat
unclassifi
restrict
dilat
arrhytmogen
right
ventricular
cardiomyopathi
identifi
cat
left
atrial
enlarg
lae
found
cat
clvh
lae
present
ucm
rcm
dcm
arvc
case
concentr
left
ventricular
hypertrophi
far
frequent
identifi
cardiac
abnorm
cat
gener
practic
form
heart
diseas
rel
rare
lae
commonli
found
cat
ucm
rcm
dcm
arvc
cat
clvh
conflict
interest
conflict
interest
report
k
creamer
dn
clement
r
mellanbi
g
culshaw
r
sv
hospit
small
anim
univers
edinburgh
edinburgh
unit
kingdom
hypothesi
studi
smartphon
applic
softwar
app
provid
easi
cheap
accur
reliabl
readili
avail
method
owner
monitor
anim
heart
rate
hr
home
aim
studi
determin
degre
correl
heart
rate
heart
rate
determin
whether
strength
correl
influenc
follow
variabl
speci
bodi
size
pant
vocal
clip
unclip
coat
anaesthetis
consciou
heart
rate
obtain
differ
commerci
avail
app
compar
simultan
record
ecg
cat
dog
refer
royal
dick
school
veterinari
studi
app
use
instant
heart
rate
monitor
ihrm
use
camera
detect
puls
heart
beat
monitor
htm
heart
monitor
hm
use
microphon
detect
heart
sound
anim
select
accord
demeanour
absenc
auscultat
arrhythmia
use
pearson
correl
signific
correl
hm
ecg
heart
rate
dog
r
p
cat
r
p
htm
dog
r
p
cat
r
p
ihrm
cat
r
p
ihrm
dog
signific
correl
ecg
deriv
heart
rate
p
r
suggest
ihrm
heart
rate
use
plot
app
high
proport
data
point
fell
outsid
confid
interv
suggest
error
consist
correct
factor
could
use
compar
hr
hm
app
size
signific
effect
dog
error
increas
significantli
larg
dog
versu
small
dog
hbm
app
error
increas
significantli
compar
larg
dog
p
medium
dog
p
versu
small
dog
also
greater
error
awak
versu
anaesthetis
cat
clip
versu
non
clip
cat
p
none
variabl
significantli
affect
error
ihrm
app
conclus
studi
fail
demonstr
select
smartphon
app
reliabl
accur
calcul
heart
rate
cat
dog
develop
smartphon
technolog
requir
allow
owner
assess
heart
rate
dog
cat
conflict
interest
conflict
interest
report
aem
albano
stockholm
univers
agricultur
scienc
uppsala
sweden
heart
rate
presenc
arrhythmia
cat
asymptomat
hypertroph
cardiomyopathi
hcm
well
investig
perform
doubl
blind
random
placebo
control
pilot
studi
use
hour
ecg
system
ie
holter
monitor
aim
determin
heart
rate
number
ventricular
ectop
complex
vec
supraventricular
ectop
complex
svec
blood
pressur
treatment
atenolol
placeboinclus
criteria
left
ventricular
later
wall
lwvd
andor
interventricular
septal
diamet
ivsd
mm
systol
blood
pressur
mmhg
absenc
cardiac
system
diseas
congest
heart
failur
chf
blood
analys
creatinin
alat
total
glucos
echocardiographi
mhz
probe
use
seven
electrod
place
ventral
thorax
provid
lead
ecg
cat
releas
roam
freeli
home
environ
hoursfifteen
privat
own
hcm
cat
differ
breed
age
year
mean
five
femal
ten
male
includ
initi
visit
echocardiographi
blood
pressur
holter
perform
ivsd
lwvd
mean
mm
mean
holter
time
hr
min
cat
treat
tablet
daili
day
atenolol
mg
placebo
revisit
blood
pressur
measur
holter
record
mean
hr
min
holter
data
manual
analys
one
author
sh
use
welch
allyn
holter
analysi
systemthre
cat
exclud
studi
due
chf
abl
medic
properli
comput
problem
treatment
mean
heart
rate
bpm
sd
cat
normal
sinu
rhythm
tall
r
wave
left
anterior
fascicular
block
appear
mild
moder
sinu
arrhythmia
median
number
vec
iqr
median
number
svec
iqr
mean
blood
pressur
mmhg
sd
cat
receiv
placebo
cat
receiv
atenolol
signific
differ
detect
within
group
compar
treatment
group
treatment
respect
heart
rate
vec
svec
blood
pressur
conclus
effect
atenolol
heart
rate
number
vec
svec
blood
pressur
result
present
studi
support
routin
treatment
asymptomat
hcm
cat
atenolol
howev
larger
number
cat
may
need
obtain
conclus
result
conflict
interest
conflict
interest
report
mp
perego
r
ferriani
ra
santilli
clinica
veterinaria
malpensa
samar
itali
manual
cardiovers
mc
procedur
use
treat
supraventricular
tachycardia
svt
perform
mc
oper
strike
blow
fist
specif
place
thorax
object
studi
describ
efficaci
mc
interrupt
svt
electrocardiograph
variat
svt
sequenc
electrocardiogram
dog
underw
electrophysiolog
studi
retrospect
analyz
nineteen
dog
differ
breed
mean
age
sd
year
mean
bodi
weight
kg
f
select
thirteen
case
mc
perform
orthodrom
atrioventricular
reciproc
tachycardia
oavrt
case
focal
atrial
tachycardia
fat
normal
distribut
valu
assess
normal
distribut
data
test
use
student
distribut
data
use
wilcoxon
sum
rank
test
case
mc
interrupt
svt
oavrt
fat
statist
differ
two
group
p
case
last
deflect
interrupt
svt
p
wave
mean
durat
paus
interrupt
msec
msec
oavrt
msec
fat
signific
longer
oavrt
case
paus
sinu
rhythm
sr
present
svt
msec
msec
oavrt
msec
fat
mc
p
r
interv
progress
prolong
patient
oavrt
msec
fat
msec
suggest
possibl
conceal
conduct
artifici
potenti
along
av
node
rp
interv
remain
unchang
case
oavrt
post
mc
msec
fat
msec
suggest
effect
accessori
pathway
retrograd
conduct
atrial
ectop
focu
discharg
rate
complic
occur
base
result
mc
consid
success
safe
procedur
transient
interrupt
svt
dog
allow
comparison
wave
svt
sr
lead
possibl
diagnosi
underli
electrogen
mechan
conflict
interest
conflict
interest
report
nj
wiedemann
stosic
e
henrich
e
hassdenteufel
n
hildebrandt
schneider
small
anim
clinic
univers
giessen
germani
cardiac
troponin
ctni
myocardi
regulatori
protein
releas
circul
follow
myocardi
injuri
use
marker
degre
myocyt
injuri
diseas
progress
offer
prognost
inform
elev
ctni
describ
dog
signific
bradyarrhythmia
caus
elev
remain
unclear
valu
post
singl
chamber
pacemak
implant
decreas
remain
refer
rang
major
case
aim
prospect
studi
evalu
av
synchron
pace
dual
chamber
pacemak
implant
reduc
possibl
normal
ctni
whether
factor
influenc
ctni
determin
dog
perman
high
grade
second
third
degre
atrioventricular
block
clinic
sign
bradyarrhythmia
requir
pacemak
implant
prospect
includ
dog
receiv
dual
chamber
pacemak
ddd
dddr
fifteen
dog
present
april
septemb
n
femal
n
male
serum
ctni
taken
prior
pacemak
implant
day
sampl
ctni
seper
frozen
within
minut
measur
ultrasensit
assay
advia
centaur
tni
ultra
siemen
diagnost
extern
laborartori
intial
present
complet
echocardiographi
conduct
index
diastol
left
ventricular
diamet
measur
publish
event
record
pacermak
analys
short
term
data
test
normal
distribut
ctni
compar
initi
examin
main
present
complaint
syncop
n
exercis
intoler
n
pant
n
one
dog
show
sign
congest
heart
failur
two
dog
suspici
atrial
mocard
mean
age
weight
year
kg
respect
initi
present
ctni
ngml
rang
ngml
ctni
concentr
decreas
significantli
ngml
ngml
p
despit
av
synchron
stimul
ctni
remain
elev
dog
left
ventricular
dimens
decreas
p
suggest
efficaci
physiolog
pace
identifi
signific
decreas
ctni
left
ventricular
size
warrant
show
longterm
benefit
physiolog
pace
caus
increas
ctni
concentr
remain
unclear
warrant
investig
conflict
interest
conflict
interest
report
kf
scollan
dd
sisson
oregon
state
univers
corval
unit
state
america
sotalol
mexiletin
commonli
use
oral
antiarrhythm
medic
treat
ventricular
arrhythmia
dog
previou
human
veterinari
studi
indic
enhanc
efficaci
combin
therapi
monotherapi
drug
one
major
limit
use
mexiletin
dog
requir
dose
everi
eight
hour
impract
imposs
mani
dog
owner
previou
veterinari
studi
reveal
higher
mexiletin
serum
level
administ
combin
sotalol
compar
level
measur
mexiletin
monotherapi
hypothes
therapeut
serum
level
mexiletin
may
maintain
twice
daili
administr
use
combin
sotalol
object
studi
assess
mexiletin
serum
level
administ
twice
daili
combin
sotalol
normal
dog
studi
protocol
approv
anim
care
use
committe
oregon
state
univers
purpos
bred
dog
four
beagl
two
hound
determin
healthi
normal
physic
echocardiograph
examin
bloodwork
receiv
twice
daili
sotalol
mgkg
twice
daili
mexiletin
mgkg
oral
ten
day
eleventh
day
whole
blood
drawn
hour
post
pill
uninterrupt
drug
administr
mexiletin
serum
level
measur
time
point
sotalol
serum
level
measur
hour
post
pill
serum
drug
concentr
measur
high
perform
liquid
chromatographi
commerci
laboratori
median
peak
serum
mexiletin
concentr
measur
hour
post
pill
ngml
rang
median
trough
concentr
measur
hour
post
pill
ngml
rang
mexiletin
serum
level
found
remain
within
describ
therapeut
rang
human
ngml
durat
hour
three
six
dog
twice
daili
administr
three
dog
includ
largest
three
dog
within
group
six
two
hound
one
beagl
compar
bodi
weight
subgroup
dog
greater
kg
n
significantli
higher
peak
trough
serum
mexiletin
level
compar
less
kg
p
respect
result
indic
therapeut
serum
mexiletin
level
maintain
twice
daili
dose
use
combin
sotalol
dog
greater
kg
therapeut
implic
efficaci
mexiletin
serum
level
affect
dog
investig
conflict
interest
conflict
interest
report
j
lee
mizuno
mizuno
k
harada
sawada
shinoda
uchida
uechi
nihon
univers
fujisawa
japan
degen
mitral
valv
diseas
dmvd
lead
caus
congest
heart
failur
chf
small
breed
dog
although
myocardi
histopatholog
chang
key
process
develop
chf
clinic
relev
fulli
evalu
aim
studi
character
patholog
alter
investig
relationship
clinic
aspect
natur
occur
dmvd
dog
biopsi
left
atrial
appendag
ventricl
la
lv
lung
taken
surgic
mitral
valv
repair
case
specif
patholog
chang
assess
la
lv
fatti
replac
myocardi
vacuol
infiltr
immun
cell
increas
perinuclear
space
enlarg
nuclei
hypertrophi
interstiti
fibrosi
well
lung
alveolar
septal
thicken
heart
failur
cell
hyperplasia
type
ii
pneumocyt
use
either
score
digit
system
quantifi
patholog
find
analyz
term
relationship
sever
isachc
commonli
use
clinic
indic
vertebr
heart
score
left
ventricular
dimens
lvedd
left
diamet
ratio
laao
fraction
shorten
fs
eject
fraction
ef
veloc
e
wave
substanti
patholog
progress
found
isachc
group
except
heart
failur
cell
significantli
increas
class
iii
p
pair
comparison
la
lv
la
significantli
sever
myocardi
fatti
replac
immun
cell
infiltr
interstiti
fibrosi
lv
p
meanwhil
cardiomyocyt
lv
hypertrophi
la
p
regress
analysi
adjust
age
bodi
weight
reveal
lvedd
well
associ
fatti
replac
p
myocardi
vacuol
p
la
interstiti
fibrosi
neg
relat
ef
la
p
lv
p
howev
fs
show
relat
patholog
variabl
also
heart
failur
cell
relat
laao
p
e
wave
p
wave
p
dmvd
sever
patholog
chang
may
progress
earli
stage
chf
mechan
injuri
la
differ
hemodynam
strain
result
mitral
regurgit
caus
patholog
dispar
la
lv
lvedd
ef
may
rel
effect
predict
myocardi
patholog
state
conflict
interest
conflict
interest
report
aem
j
k
anim
hospit
danderyd
clinic
scienc
faculti
veterinari
medicin
uppsala
anatomi
physiolog
biochemistri
uppsala
sweden
pulmonari
arteri
hypertens
pah
common
sequela
myxomat
mitral
valv
diseas
mmvd
dog
may
influenc
surviv
dog
pah
may
present
without
measur
tricuspid
regurgit
tr
would
use
identifi
echocardiograph
variabl
identifi
pah
dog
aim
studi
correl
estim
right
ventricular
systol
pressur
rvsp
equal
pulmonari
arteri
systol
pressur
pasp
absenc
pulmon
stenosi
ps
variou
echocardiograph
variabl
dog
mmvd
measur
tr
total
dog
differ
breed
mmvd
detect
tr
evid
ps
includ
studi
accord
acvim
classif
congest
heart
failur
chf
dog
classifi
chf
dog
without
chf
tr
veloc
subject
estim
right
atrial
ra
pressur
use
indirectli
assess
rvsp
ra
pressur
arbitrarili
consid
mm
hg
absenc
ra
enlarg
mm
hg
presenc
ra
enlarg
none
dog
present
sign
chf
rvsp
rang
mm
hg
dog
dichotom
group
tr
ms
correspond
rvsp
mm
hg
n
tr
ms
correspond
rvsp
mm
hg
n
signific
differ
group
regard
age
bodi
weight
sex
percentag
increas
left
ventricular
intern
diamet
lvidd
inc
heart
rate
p
left
atrial
diamet
aortic
diamet
ratio
laao
p
significantli
higher
group
compar
group
estim
rvsp
correl
decreas
pulmonari
arteri
pa
acceler
time
deceler
time
ratio
atdt
right
ventricular
intern
diamet
rvidd
correl
bodi
weight
correl
rvsp
tricuspid
annular
plane
systol
excurs
taps
pa
flow
veloc
multipl
regress
analysi
rvsp
depend
variabl
atdt
p
p
remain
signific
final
model
adjust
valu
conclus
presenc
pah
may
suspect
decreas
atdt
ratio
increas
dog
mmvd
conflict
interest
conflict
interest
report
c
g
p
pg
c
degli
studi
di
milano
milan
veterinaria
gran
sasso
milan
itali
although
multipl
method
describ
quantit
right
ventricl
rv
assess
use
standard
transthorac
echocardiographi
assess
rv
structur
function
remain
mostli
qualit
clinic
practic
sever
base
techniqu
develop
assess
myocardi
function
angl
independ
way
differ
base
type
algorithm
employ
first
investig
method
known
speckl
track
second
one
known
featur
track
fte
fte
softwar
base
dedic
algorithm
follow
frame
frame
endocardi
border
actual
process
system
base
technolog
aim
studi
determin
refer
valu
longitudin
rv
global
region
segment
basal
middl
apic
septum
basal
middl
apic
later
wall
peak
systol
strain
st
strain
rate
sr
use
fte
clinic
healthi
dog
cineloop
acquir
left
parastern
standard
chamber
apic
view
optim
rv
mhz
probe
gold
system
esaot
florenc
analyz
regard
st
sr
use
xstrain
softwar
base
fte
algorithm
variabl
mean
measur
use
statist
analysi
influenc
age
gender
bodi
weight
heart
rate
hr
type
breed
non
athlet
versu
athlet
st
sr
variabl
test
multivari
analysi
varianc
analysi
varianc
use
investig
differ
myocardi
segment
sixti
dog
non
athlet
athlet
prospect
includ
studi
femal
male
mean
age
year
bodyweight
kg
hr
beat
per
minut
refer
valu
establish
everi
myocardi
segment
bodi
weight
type
breed
show
statist
signific
effect
st
sr
variabl
analyz
p
rv
septal
longitudin
st
sr
variabl
significantli
higher
base
compar
apex
p
later
wall
compar
septum
p
conclus
fte
assess
longitudin
rv
st
sr
feasibl
healthi
dog
reveal
septal
longitudin
apex
base
gradient
st
sr
variabl
shown
influenc
bodi
weight
type
breed
non
athlet
versu
athlet
studi
need
confirm
result
conflict
interest
conflict
interest
report
jm
gentil
ja
abbott
virginia
tech
blacksburg
unit
state
america
pauciti
publish
norm
echocardiograph
data
relat
structur
function
canin
right
heart
accordingli
sought
defin
echocardiograph
refer
interv
dimens
canin
right
heart
describ
measur
variabl
echocardiograph
indic
right
heart
structur
function
healthi
dog
divers
somatotyp
bodi
weight
bw
subject
echocardiograph
examin
singl
oper
six
dog
randomli
select
undergo
twice
daili
echocardiograph
examin
two
oper
three
day
describ
repeat
echocardiograph
indic
use
estim
pulmonari
arteri
pressur
four
clinic
stabl
dog
tricuspid
valv
regurgit
tr
also
subject
repeat
echocardiograph
examin
raw
data
healthi
dog
subject
logarithm
transform
allometr
relationship
bodi
size
echocardiograph
variabl
determin
refer
interv
intend
includ
popul
defin
mix
model
develop
evalu
fix
effect
oper
day
random
effect
subject
measur
variabl
describ
calcul
repeat
coeffici
rc
varianc
compon
also
express
coeffici
variat
cv
strength
linear
relationship
transform
variabl
bw
variabl
rang
coeffici
determin
linear
dimens
scale
expon
deriv
allometr
equat
measur
chamber
area
scale
expon
two
calcul
cv
less
cv
variabl
gener
higher
two
dimension
echocardiographi
rang
rc
linear
dimens
mm
area
analog
rc
peak
tr
veloc
ms
rc
peak
tr
veloc
ms
rang
cv
tr
veloc
refer
interv
echocardiograph
dimens
indic
right
heart
function
propos
select
linear
dimens
area
obtain
accept
repeat
oper
obtain
serial
measur
chang
tr
veloc
exceed
ms
outsid
expect
rang
measur
variat
conflict
interest
conflict
interest
report
studi
fund
grant
provid
profit
virginia
veterinari
medic
associ
veterinari
memori
fund
repres
conflict
interest
js
je
p
tp
bj
sm
h
bk
tc
jm
lb
rl
wa
laboratori
westbrook
unit
state
pennsylvania
philadelphia
pa
unit
state
univers
north
grafton
unit
state
medic
center
new
york
ny
unit
state
worthington
oh
unit
state
wisconsin
madison
wi
unit
state
univers
colleg
station
tx
unit
state
veterinari
cardiolog
associ
vienna
va
unit
state
carolina
state
univers
raleigh
nc
unit
state
veterinari
group
woburn
unit
state
cardiolog
consult
novi
mi
unit
state
america
increas
dog
heart
diseas
differenti
symptomat
respiratori
diseas
heart
failur
stratifi
heart
diseas
sever
howev
canin
assay
limit
dynam
rang
reduc
clinic
util
biomark
canin
patient
sever
heart
diseas
address
limit
new
assay
canin
develop
extend
upper
limit
quantit
method
comparison
conduct
retrospect
evalu
clinic
perform
assay
use
sampl
previou
multicent
trial
concentr
dog
respiratori
sign
heart
diseas
heart
failur
preliminari
result
prospect
multicent
field
studi
oyama
et
al
ecvim
patient
recruit
referr
center
prospect
assign
one
group
base
upon
physic
exam
ecg
radiograph
echocardiographi
group
healthi
control
group
asymptomat
heart
diseas
group
respiratori
sign
attribut
congest
heart
failur
group
respiratori
sign
attribut
primari
respiratori
airway
diseas
dog
cardiac
diseas
categor
attend
dvm
insignific
mildmoder
sever
cardiac
diseas
plasma
sampl
origin
collect
retain
suffici
volum
inclus
comparison
studi
rang
assay
respect
analysi
indic
overal
bia
pmoll
assay
statist
insignific
p
assay
patient
group
differenti
statist
signific
p
use
cutoff
assay
equal
distinguish
chf
primari
respiratori
diseas
sensit
specif
first
assay
respect
dog
diagnos
cardiac
diseas
similarli
distinguish
diseas
sever
statist
signific
median
group
current
assay
group
iqr
n
group
n
group
n
p
median
group
assay
group
n
group
n
group
n
p
new
assay
canin
demonstr
equival
clinic
perform
predecessor
offer
increas
dynam
rang
better
support
clinic
util
canin
patient
sever
heart
diseas
conflict
interest
present
author
employe
idexx
laboratori
offer
commerci
assay
canin
g
mj
del
j
teach
hospit
murcia
univers
murcia
veterinari
medicin
surgeri
univers
murcia
spain
murcia
spain
pharmacolog
tranquil
sometim
necessari
aid
simplifi
echocardiograph
examin
dog
obtain
scan
good
qualiti
effect
sedat
acepromazin
ace
butorphanol
echocardiograph
variabl
includ
global
strain
gs
report
previous
dog
hypothes
combin
minim
effect
cardiac
function
six
healthi
dog
kg
bodi
weight
differ
breed
labrador
retriev
golden
retriev
dalmatian
spanish
podenco
hound
dog
mongrel
use
studi
transthorac
echocardiograph
examin
color
flow
doppler
spectral
doppler
tdi
perform
use
commerci
echocardiograph
system
philip
minut
sedat
combin
ace
mgkg
mgkg
administ
intramuscularli
radial
longitudin
global
strain
left
ventricl
lv
determin
via
speckl
track
echocardiographi
offlin
analysi
qlab
softwar
applic
packag
use
parastern
short
axi
imag
midpapillari
muscl
level
left
parastern
apic
imag
follow
paramet
measuredcalcul
heart
rate
hr
lv
measur
shorten
fraction
lv
outflow
tract
left
atrial
dimens
laao
lv
volum
eject
fraction
cardiac
output
mitral
aortic
pulmonari
blood
flow
measur
myocardi
perform
index
systol
time
interv
tdi
veloc
septal
lv
later
mitral
annulu
right
ventricular
tricuspid
annulu
ea
index
ee
lv
radial
longitudin
gs
statist
analysi
perform
comput
softwar
epss
differ
paramet
prior
sedat
assess
either
pair
student
test
wilcoxon
sign
rank
sum
test
p
consid
statist
signific
combin
well
toler
good
degre
sedat
requir
minim
restraint
achiev
except
dog
present
pant
sedat
follow
paramet
significantli
modifi
sedat
decreas
hr
beatsmin
lv
diastol
volum
ml
lv
radial
gs
increas
lv
free
wall
thick
cm
conclus
sedat
dose
use
studi
show
littl
influenc
echocardiograph
measur
cardiac
function
conflict
interest
conflict
interest
report
ac
e
al
p
g
c
k
mc
libr
de
bruxel
brussel
belgium
earli
recognit
left
congest
heart
failur
chf
dog
myxomat
mitral
valv
diseas
mmvd
clinic
import
thorac
radiographi
consid
clinic
gold
standard
sever
variabl
left
ventricular
fill
test
success
recent
novel
echocardiograph
index
pulmonari
vein
pulmonari
arteri
diamet
ratio
pvpa
might
help
distinguish
dog
chf
compensatori
state
aim
studi
investig
pvpa
could
predict
chf
dog
mmvd
prospect
studi
dog
recruit
includ
healthi
dog
dog
mmvd
includ
isachc
stage
stage
stage
base
physic
examin
dog
thorac
radiograph
dog
radiograph
assess
sign
chf
use
composit
score
base
cardiomegali
sign
venou
congest
lung
pattern
two
reader
blind
regard
echocardiograph
result
pvpa
measur
bd
mm
end
wave
two
investig
blind
radiograph
result
variabl
pvpa
ident
bd
mm
coeffici
variat
pvpa
bd
highli
correl
pvpa
mm
r
p
pvpa
mm
lower
healthi
dog
compar
dog
mmvd
stage
p
gradual
increas
isachc
stage
stage
stage
p
bd
pvpa
healthi
mmvd
stage
dog
differ
mmvd
stage
p
pvpa
bd
mm
correl
echocardiograph
left
ventricular
fill
indic
index
left
atrial
laao
left
ventricular
size
lviddao
edvi
p
ea
ratio
p
pvpa
ratio
increas
dog
composit
radiograph
score
compar
dog
score
area
characterist
curv
show
valu
pvpa
ratio
mm
bd
predict
chf
dog
mmvd
sensit
specif
respect
pvpa
ratio
simpl
reproduc
sensit
specif
echocardiograph
index
contribut
assess
chf
statu
dog
mmvd
birettoni
et
al
novel
echocardiograph
index
dog
pulmonari
vein
pulmonari
arteri
diamet
congress
conflict
interest
conflict
interest
report
g
kiss
f
manczur
faculti
veterinari
scienc
szent
univers
budapest
hungari
gene
express
analyz
method
eg
microarray
wide
use
today
studi
complex
diseas
process
cardiolog
research
major
obstacl
studi
limit
avail
heart
tissu
sampl
previou
studi
show
lymphocyt
peripher
blood
reflect
express
profil
sever
organ
includ
heart
human
due
interact
blood
cell
everi
tissu
microenviron
bodi
blood
base
express
profil
may
offer
power
tool
screen
molecular
event
heart
diseas
cours
research
aim
investig
correl
gene
express
mrna
profil
heart
peripher
blood
dog
chronic
heart
failur
heart
tissu
blood
sampl
collect
rna
isol
anim
use
purpos
approv
human
medic
research
project
tachypac
induc
cardiomyopathi
dog
sever
decreas
contractil
n
compar
healthi
control
n
pool
sampl
equal
gender
ratio
whole
blood
obtain
special
sampl
tube
suitabl
immedi
total
rna
stabil
storag
cardiac
left
ventricular
free
wall
transmur
tissu
sampl
collect
rnalat
solut
euthanasia
isol
total
rna
quantiti
qualiti
control
spectrophotometri
capillari
electrophoresi
prove
proper
gene
express
profil
gene
express
level
measur
dual
color
microarray
method
oligonucleotid
microarray
format
cover
total
canin
transcriptom
result
show
differ
express
transcript
fold
chang
student
multipl
test
correct
p
two
technic
repeat
heart
failur
control
group
heart
sampl
transcript
could
identifi
similarli
also
blood
sampl
subgroup
consist
numer
mrna
transcript
relat
extracellular
matrix
protein
inflammatori
stress
respons
connect
tissu
turnov
apoptosi
contractil
eg
versican
osteopontin
heat
shock
collagen
matrix
protein
kinas
chemokin
ligand
fibroblast
growth
factor
myosin
heavi
pathway
analysi
result
fibrosi
main
signific
process
find
line
major
characterist
tachypac
induc
model
describ
literatur
decreas
contractil
fibrosi
remodel
result
suggest
blood
may
reflect
gene
express
chang
dog
heart
failur
conflict
interest
conflict
interest
report
mj
j
j
je
lh
copenhagen
frederiksberg
univers
agricultur
scienc
uppsala
univers
hospit
odens
denmark
endotheli
dysfunct
repres
therapeut
target
suggest
associ
myxomat
mitral
valv
diseas
mmvd
dog
tetrahydrobiopterin
import
cofactor
product
vasodil
nitric
oxid
condit
oxid
stress
oxidis
biolog
inact
form
dihydrobiopterin
thu
plasma
level
suggest
reflect
endotheli
function
aim
studi
determin
plasma
concentr
dog
differ
degre
natur
occur
mmvd
clinic
examin
includ
echocardiographi
perform
dog
control
dog
beagl
cavali
king
charl
spaniel
differ
degre
mmvd
dog
differ
breed
clinic
sign
congest
heart
failur
chf
due
mmvd
plasma
level
measur
high
perform
liquid
chromatographi
hplc
fluoresc
detect
differ
diseas
group
test
use
multipl
linear
regress
dog
chf
significantli
higher
level
dog
group
p
level
found
increas
advanc
age
p
femal
higher
level
p
risk
factor
passiv
smoke
p
increas
bodi
weight
p
associ
decreas
level
conclus
age
gender
bodi
weight
passiv
smoke
plasma
cardiac
statu
correl
plasma
concentr
dog
conflict
interest
employ
univers
copenhagen
affili
research
center
lifepharm
partli
financ
novo
nordisk
drut
riba
f
floch
c
cottin
b
rannou
l
freyburg
franchequin
jl
bublot
vetagro
sup
lyon
marci
letoil
franc
physiolog
heart
murmur
phm
origin
normal
flow
pattern
absenc
abnorm
heart
great
vessel
describ
young
anim
less
month
patholog
condit
alter
pattern
blood
flow
anemia
fever
phm
document
adult
boxer
athlet
dog
preval
gener
popul
adult
dog
unknown
distinguish
physiolog
patholog
murmur
otherwis
healthi
anim
may
challeng
clinician
object
studi
assess
preval
phm
healthi
young
adult
dog
pilot
studi
perform
novemb
april
dog
suggest
high
preval
phm
popul
object
main
studi
evalu
preval
phm
larger
popul
dog
hundr
overtli
healthi
dog
year
age
enrol
juli
via
prevent
medicin
consult
dog
undergo
complet
physic
examin
cardiac
auscult
three
observ
blind
ad
tr
jlc
anim
submit
complet
blood
count
serum
total
protein
blood
pressur
measur
exclud
abnorm
potenti
caus
heart
murmur
murmur
time
grade
point
maxim
intens
record
exclud
cardiac
abnorm
complet
echocardiograph
examin
perform
day
auscult
everi
dog
murmur
auscult
least
one
observ
echocardiograph
ib
blind
murmur
characterist
far
dog
enrol
exclud
murmur
heard
dog
base
echocardiographi
murmur
consid
phm
remain
dog
two
acceler
aortic
flow
veloc
one
mvd
four
phm
auscult
three
observ
phm
heard
two
observ
phm
note
one
observ
phm
systol
low
grade
point
maxim
intens
left
base
andor
manubrium
dog
remain
dog
observ
reach
agreement
local
signific
differ
bodi
weight
dog
phm
mean
kg
dog
without
murmur
mean
kg
final
result
includ
preval
characterist
phm
correl
observ
popul
characterist
present
conflict
interest
conflict
interest
report
c
g
p
c
degli
studi
di
milano
milan
veterinaria
gran
sasso
milan
itali
patent
ductu
arteriosu
pda
one
common
congenit
heart
defect
dog
caus
mark
left
ventricular
volum
overload
lvvo
lead
cardiac
remodel
final
congest
heart
failur
pulmonari
system
flow
ratio
qp
qs
ratio
one
criteria
describ
quantif
pda
shunt
veterinari
medicin
pda
induc
lvvo
also
quantifi
standard
transthorac
volum
equat
tte
echocardiographi
ste
angl
independ
imag
modal
increasingli
use
evalu
region
well
global
cardiac
function
differ
clinic
scenariosth
aim
studi
assess
global
circumferenti
radial
longitudin
strain
strainrat
sr
ste
valu
dog
pda
healthi
young
dog
compar
data
standard
echocardiograph
paramet
shunt
lvvo
dog
underw
complet
echocardiograph
studi
cineloop
right
parastern
short
axi
view
mitral
valv
papillari
muscl
apic
level
left
parastern
chamber
view
acquir
analys
regard
st
sr
use
xstrain
tm
softwar
esaot
florenc
variabl
mean
beat
use
statist
analysi
dog
pda
show
statist
higher
compar
normal
dog
p
statist
differ
found
global
sr
compar
dog
pda
vs
control
dog
mean
global
circumferenti
sr
higher
p
dog
pda
compar
healthi
control
dogsmean
global
radial
sr
higher
p
dog
pda
compar
healthi
control
dogslongitudin
sr
higher
p
dog
pda
compar
healthi
control
dogsthes
find
suggest
pda
associ
increas
sr
valu
complementari
tool
togeth
standard
order
better
assess
cardiac
function
patient
conflict
interest
conflict
interest
report
cc
bc
rm
jm
ae
js
laboratori
texa
univers
colleg
station
unit
state
state
univers
ame
unit
state
america
combin
alter
composit
gi
microbi
commun
dysbiosi
underli
host
genet
suscept
environment
factor
suspect
contribut
pathogenesi
idiopath
inflammatori
bowel
diseas
ibd
despit
well
document
evid
intestin
microb
play
pivot
role
pathogenesi
ibd
actual
mechan
interact
remain
elus
believ
mediat
part
microbi
product
metabolit
deriv
gi
microbiota
howev
limit
inform
avail
serum
metabolit
concentr
fecal
microbi
commun
dog
ibd
aim
studi
evalu
serum
metabolit
concentr
fecal
microbiota
dog
ibd
medic
therapi
disord
serum
fecal
sampl
collect
healthi
dog
n
dog
ibd
n
day
standard
medic
therapi
eg
elimin
diet
administr
drug
diseas
statu
assess
use
clinic
diseas
activ
index
cibdai
fecal
dna
evalu
fecal
microbi
composit
use
rrna
gene
quantit
pcr
qpcr
serum
metabolit
profil
use
platform
analyz
use
metaboanalyst
sequenc
analysi
perform
use
qiim
treatment
abund
blautia
faecalibacterium
turicibact
significantli
decreas
dog
ibd
p
respect
rel
healthi
dog
unifrac
analysi
reveal
cluster
healthi
diseas
dog
anosim
p
cibdai
significantli
decreas
signific
differ
proport
bacteri
group
found
treatment
serum
analysi
reveal
annot
metabolit
serum
concentr
sever
metabolit
differ
significantli
healthi
dog
dog
ibd
decreas
ibd
tyrosin
aminomalon
acid
naphthalen
prolin
increas
ibd
xylitol
allantoin
howev
signific
chang
concentr
metabolit
observ
treatment
conclus
alter
serum
concentr
metabolit
fecal
dysbiosi
observ
dog
ibd
although
clinic
improv
observ
treatment
accompani
signific
chang
fecal
microbiota
serum
metabolit
concentr
longer
period
treatment
differ
approach
medic
therapi
ie
may
need
dog
recov
fecal
dysbiosi
associ
ibd
conflict
interest
conflict
interest
report
n
sb
keyser
cs
bridg
rm
heilmann
js
suchodolski
jm
steiner
gastrointestin
laboratori
colleg
station
unit
state
america
recent
search
gastrointestin
laboratori
gi
lab
databas
show
hypocobalaminemia
frequent
observ
greyhound
unknown
malabsorpt
cobalamin
micronutri
eg
folat
due
chronic
gastrointestin
diseas
play
role
caus
find
greyhound
cobalamin
folat
absorb
distal
proxim
small
intestin
respect
human
low
serum
cobalamin
folat
concentr
associ
increas
serum
homocystein
hci
concentr
reflect
lack
intracellular
avail
vitamin
increas
serum
hci
concentr
associ
cardiovascular
thrombot
diseas
human
condit
also
describ
greyhound
therefor
aim
studi
evalu
frequenc
hypofolatemia
hypocobalaminem
greyhound
serum
hci
concentr
hypocobalaminem
hypofolatem
greyhound
submiss
greyhound
n
gi
lab
analysi
serum
cobalamin
folat
concentr
review
hypocobalaminem
greyhound
serum
cobalamin
concentr
lower
limit
refer
interv
ri
ngl
identifi
investig
proport
dog
concurr
hypofolatemia
serum
folat
concentr
ri
calcul
odd
ratio
confid
interv
ci
also
serum
sampl
greyhound
submit
laboratori
octob
march
use
measur
serum
hci
concentr
ri
ga
chromatographymass
spectrometri
u
test
use
compar
serum
hci
concentr
hypocobalaminem
hypofolatem
greyhound
normocobalaminem
normofolatem
greyhound
p
consid
signific
studi
hypofolatemia
frequent
observ
hypocobalaminem
greyhound
normocobalaminem
greyhound
ci
p
although
signific
serum
hci
concentr
higher
hypocobalaminem
hypofolatem
greyhound
n
median
compar
normocobalaminem
normofolatem
greyhound
n
median
p
hyperhomocysteinemia
detect
hypocobalaminem
hypofolatem
greyhound
normocobalaminem
normofolatem
greyhound
hypocobalaminemia
greyhound
associ
hypofolatemia
increas
serum
hci
concentr
observ
hypocobalaminem
hypofolatem
greyhound
also
greyhound
normal
serum
concentr
vitamin
suggest
lack
vitamin
intracellular
level
function
implic
find
greyhound
warrant
studi
conflict
interest
conflict
interest
report
j
k
j
rs
k
small
anim
medicin
munich
germani
munich
lab
texa
univers
colleg
station
unit
state
america
associ
clostridi
pathogen
idiopath
acut
haemorrhag
diarrhoea
syndrom
ahd
dog
describ
howev
clinic
relev
presenc
clostridium
c
spp
toxin
fece
evalu
far
thu
aim
studi
evalu
associ
sever
clinic
sign
presenc
c
perfringen
enterotoxin
cpe
c
difficil
toxin
ab
ab
fece
dog
ahd
fecal
sampl
dog
idiopath
ahd
test
qualit
cpe
elisa
addit
genotyp
perform
detect
enterotoxin
gene
c
perfringen
cpe
toxin
b
gene
c
difficil
tcdb
sever
clinic
sign
durat
hospit
mortal
rate
select
laboratori
paramet
hematocrit
band
neutrophil
bilirubin
albumin
compar
dog
well
toxin
fecal
sampl
cpe
found
fecal
sampl
dog
idiopath
ahd
cpe
cpe
cpe
detect
tcdb
tcdb
dog
signific
differ
could
detect
paramet
evalu
neither
dog
result
studi
suggest
cpe
play
signific
role
dog
idiopath
ahd
valu
measur
toxin
predict
sever
outcom
diseas
conflict
interest
conflict
interest
report
schmitz
b
glanemann
oa
garden
werl
k
allenspach
royal
veterinari
colleg
north
mymm
unit
kingdom
canin
chronic
enteropathi
ce
thought
partial
caus
aberr
immun
respons
toward
intestin
microbiom
human
mice
administr
probiot
allevi
coliti
sever
andor
prevent
relaps
induct
toler
microenviron
effect
probiot
enterococcu
faecium
ncimb
ef
demonstr
canin
whole
blood
cultur
canin
duoden
biopsi
aim
studi
investig
effect
ef
gene
express
duoden
colon
biopsi
dog
diagnos
ce
fce
dog
recruit
receiv
ef
manner
addit
exclus
diet
hydrolys
protein
duoden
colon
biopsi
taken
week
start
treatment
rna
extract
biopsi
quantit
pcr
perform
assay
follow
gene
rorc
ifni
ppari
use
dilut
plasmid
control
gene
assess
assay
effici
rel
quantif
gene
express
perform
use
four
refer
gene
duodenum
colon
comparison
gene
express
treatment
treatment
group
wilcoxon
sign
rank
test
mann
whitney
test
perform
respect
signific
set
p
twelv
dog
finish
clinic
trial
receiv
ef
food
eff
placebo
pf
six
week
begin
treatment
significantli
reduc
gene
express
found
duoden
tissu
pf
group
rorc
ppari
colon
signific
increas
express
test
gene
apart
cell
cytokin
rorc
seen
pf
group
first
studi
demonstr
profound
effect
treatment
canin
fce
sever
gene
innat
adapt
immun
system
found
duodenum
wherea
gene
express
nearli
examin
gene
increas
colon
tissu
placebo
group
despit
clinic
improv
seen
dog
howev
number
dog
studi
compar
small
make
bia
due
sampl
size
possibl
similar
investig
complement
assess
protein
express
perform
larger
number
dog
suffer
differ
type
ce
conflict
interest
work
present
part
phd
support
protexin
veterinari
ltd
somerset
uk
bbsrc
n
u
b
k
e
jg
medicin
vienna
anim
breed
genet
biomodel
austria
vienna
patholog
forens
medicin
univers
veterinari
medicin
vienna
clinic
scienc
servic
royal
veterinari
colleg
hattfield
hert
unit
kingdom
chronic
intestin
inflammatori
disord
inflammatori
bowel
diseas
ibd
observ
increas
frequenc
canin
patient
molecular
pathogenesi
canin
ibd
multifactori
seem
involv
similar
pathogenet
mechan
ad
human
ibd
mous
model
human
ibd
despit
multifactori
pathogenesi
diseas
variou
cytokin
express
correl
grade
tissu
inflamm
andor
damag
provid
opportun
find
marker
diseas
outcom
human
ibd
murin
ibd
model
transcript
factor
activ
epitheli
cell
interleukin
contribut
substanti
wound
heal
epitheli
regener
although
express
activ
intestin
mucosa
human
chronic
enteropathi
patient
well
mous
model
well
studi
data
avail
dog
thu
aim
project
investig
role
canin
ibd
ten
dog
chronic
gastrointestin
sign
includ
prospect
studi
two
dog
euthan
due
non
gastrointestin
diseas
beagl
dog
serv
control
patient
assess
given
clinic
score
use
cibdai
ccecai
score
system
underw
gastrointestin
endoscopi
use
mucos
biopsi
specimen
duodenum
immunohistolog
stain
perform
detect
phosphoryl
activ
found
exclus
express
cell
eg
macrophag
lymphocyt
intestin
stroma
human
ibd
patient
ibd
mous
model
activ
mainli
found
epitheli
cell
hallmark
inflamm
regener
process
intestin
epithelium
discrep
could
due
fact
canin
ibd
epithelium
larg
intact
regener
epithelium
may
play
minor
role
pathogenesi
diseas
conflict
interest
conflict
interest
report
je
slovak
c
otoni
c
wang
ae
jergen
iowa
state
univers
ame
unit
state
america
endoscopi
gold
standard
evalu
chronic
enteropathi
reliabl
assess
endoscop
lesion
unclear
previou
studi
provid
conflict
result
benefit
endoscop
activ
diagnosi
manag
intestin
diseas
moreov
mucos
criteria
vari
trial
may
creat
confus
confound
accur
interpret
endoscopist
aim
present
studi
develop
valid
endoscop
index
assess
sever
chronic
enteropathi
compar
role
oper
experi
mucos
interpret
total
endoscop
imag
inflammatori
normal
mucosa
dog
chronic
enteropathi
display
expert
novic
endoscopist
pictur
assess
independ
endoscopist
inflammatori
chang
use
establish
indic
ie
hyperemia
granular
friabil
lymphat
dilat
eros
mass
interpret
normal
mucosa
expert
endoscopist
defin
individu
advanc
clinic
train
activ
oper
particip
gastrointestin
endoscopi
preced
month
novic
endoscopist
minim
endoscop
train
lack
consist
endoscop
oper
experi
month
period
mix
effect
logist
regress
model
use
mean
valu
compar
agreement
novic
expert
endoscopist
organ
p
valu
regard
indic
statist
signific
agreement
rate
expert
novic
endoscopist
excel
good
recognit
endoscop
sign
pattern
granular
friabil
eros
lymphat
dilat
mass
normal
mucosa
poor
hyperemia
signific
differ
mucos
assess
stomach
p
colon
p
oper
group
observ
signific
differ
p
observ
small
intestin
repeat
duoden
assess
aid
use
test
set
repres
mucos
lesion
improv
overal
score
novic
endoscopist
near
experienc
endoscopist
p
oper
group
duoden
hyperemia
show
greatest
chanc
p
disagr
compar
mucos
abnorm
organ
result
indic
train
oper
identifi
endoscop
lesion
mucos
inflamm
reliabl
overal
score
endoscop
sever
base
presenc
granular
friabil
lymphat
dilat
eros
mass
hyperemia
novic
endoscopist
identifi
endoscop
appear
improv
oper
experi
conflict
interest
conflict
interest
report
mr
pj
p
cm
f
aj
anim
teach
hospit
neston
unit
veterinari
specialist
higham
gobion
unit
down
specialist
referr
bletchingley
unit
kingdom
upper
gastrointestin
foreign
bodi
acut
pancreat
similar
clinic
present
rapid
distinct
two
condit
import
emerg
case
one
diagnost
option
measur
serum
canin
lipas
cpli
sensit
specif
biomark
pancreat
inflammatori
diseas
howev
data
regard
perform
clinic
set
spars
aim
assess
serum
cpli
concentr
dog
upper
gastrointestin
foreign
bodi
retrospect
observ
cohort
studi
case
record
dog
refer
three
referr
centr
januari
decemb
review
dog
includ
gastric
small
intestin
foreign
bodi
remov
coeliotomi
serum
submit
cpli
measur
signal
present
clinic
sign
clinicopatholog
diagnost
imag
find
foreign
bodi
locat
outcom
record
total
medic
record
retriev
dog
met
inclus
criteria
dog
group
increas
pli
spec
spec
abnorm
trademark
dog
normal
cpli
group
b
differ
group
signal
present
sign
foreign
bodi
locat
surviv
discharg
diagnosi
concurr
pancreat
base
clinic
sonograph
find
made
dog
group
conclus
serum
cpli
frequent
increas
dog
upper
gastrointestin
foreign
bodi
increas
cpli
detect
gastrointestin
foreign
bodi
must
remain
differenti
diagnosi
exclud
appropri
diagnost
imag
conflict
interest
conflict
interest
report
f
mortier
yoo
k
strohmey
k
hartmann
unter
munich
germani
prospect
descript
studi
includ
larg
number
dog
idiopath
acut
hemorrhag
diarrhoea
syndrom
ahd
publish
far
aim
studi
describ
signal
histori
clinic
sign
laboratori
valu
dog
ahd
one
hundr
eight
dog
prospect
enrol
inclus
criterion
acut
hemorrhag
diarrhoea
day
dog
diseas
known
caus
bloodi
diarrhoea
exclud
clinic
assess
perform
calcul
ahd
activ
index
maximum
index
hospit
popul
serv
control
group
dog
ahd
significantli
lower
median
bodi
weight
kg
age
year
compar
control
dog
kg
year
p
sex
predilect
could
observ
predispos
breed
yorkshir
terrier
miniatur
pinscher
miniatur
schnauzer
miniatur
poodl
maltes
dog
syndrom
like
occur
winter
month
p
vomit
preced
onset
bloodi
diarrhoea
case
median
ahd
index
rang
hematocrit
gener
high
mean
rang
exceed
dog
hematocrit
dog
refer
rang
monocyt
segment
band
neutrophil
count
ahd
occur
commonli
small
breed
dog
winter
hematocrit
elev
case
exceed
two
third
dog
conflict
interest
conflict
interest
report
g
illinoi
urbana
unit
state
purina
petcar
st
loui
unit
state
america
weight
loss
malabsorpt
fat
protein
cobalamin
tocopherol
face
normal
exocrin
pancreat
function
report
cat
older
year
age
fed
varieti
nutrit
balanc
dri
wet
food
patil
ap
cupp
cj
proc
compan
anim
nutr
summit
focu
gastroenterolog
primari
object
studi
determin
common
malabsorpt
enteropathi
geriatr
cat
associ
enter
protein
loss
assess
assay
fecal
inhibitor
secondari
object
determin
correct
subnorm
serum
cobalamin
concentr
improv
observ
abnorm
fecal
studi
evalu
cat
older
year
age
increas
fecal
fat
without
exocrin
pancreat
insuffici
epi
assess
assay
serum
immunoreact
ftli
enter
protein
loss
assess
immunoassay
fecal
recent
describ
burk
kf
et
al
vet
j
http
serum
cobalamin
ftli
assay
competit
bind
assay
perform
gi
laboratori
texa
univers
evalu
use
refer
rang
deriv
laboratori
serum
albumin
assess
use
routin
serum
biochem
analysi
cat
abnorm
high
fecal
fat
serum
ftli
lower
limit
refer
rang
elimin
epi
caus
steatorrhea
serum
cobalamin
subnorm
ngl
cat
fecal
refer
rang
cat
rang
two
month
cobalamin
supplement
initi
serum
cobalamin
lower
limit
refer
rang
cat
fecal
abnorm
high
rang
cat
cat
normal
serum
albumin
concentr
time
point
evalu
conclud
enteropathi
character
nutrient
malabsorpt
geriatr
cat
also
associ
enter
protein
loss
assess
fecal
concentr
serum
albumin
remain
normal
despit
enteropathi
cat
evalu
studi
correct
subnorm
serum
cobalamin
concentr
cat
improv
abnorm
fecal
concentr
conflict
interest
david
william
consult
founder
gi
laboratori
perform
assay
util
studi
hs
k
j
r
j
jm
ce
faculti
univers
zurich
zurich
veterinari
medicin
utrecht
univers
utrecht
veterinari
medicin
biomed
scienc
texa
univers
texa
unit
state
america
assum
approxim
diabet
cat
type
diabet
mellitu
dm
remain
cat
diabet
caus
underli
diseas
recent
studi
suggest
percentag
secondari
diabet
form
especi
dm
due
acromegali
pancreat
much
higher
previous
suspect
aim
studi
evalu
circul
concentr
fpli
uccr
estim
preval
acromegali
hyperthyroid
pancreat
hypercortisol
dm
cat
two
differ
countri
privat
veterinarian
switzerland
ch
netherland
nl
ask
provid
blood
urin
sampl
diabet
cat
treat
insulin
least
week
analyz
igfbp
block
ria
fpli
elisa
spec
fpl
uccr
hous
ria
urin
corticoid
ngdl
consid
suspici
acromegali
respect
valu
hyperthyroid
pancreat
nmoll
fpli
hypercortisol
consid
exclud
uccr
x
blood
sampl
avail
cat
urin
sampl
collect
home
avail
cat
concentr
rang
ngml
median
cat
ngml
ch
nl
concentr
rang
nmoll
median
cat
elev
concentr
ch
nl
fpli
rang
median
elev
cat
ch
nl
uccr
rang
x
median
x
cat
uccr
x
ch
nl
find
differ
significantli
countri
preval
increas
lower
previous
report
sinc
high
necessarili
reflect
acromegali
ct
studi
underway
evalu
cat
mass
pituitari
gland
preval
increas
compar
preval
hyperthyroid
elderli
cat
popul
increas
uccr
rel
frequent
find
howev
none
cat
show
appropri
clinic
sign
hypothes
hypercortisol
rare
caus
felin
dm
increas
fpli
cat
may
reflect
subclin
pancreat
emerg
cours
dm
conflict
interest
conflict
interest
report
lfe
p
hp
j
e
ghent
merelbek
veterinari
medicin
ghent
univers
merelbek
national
de
de
toulous
toulous
health
medicin
life
scienc
ghent
univers
ghent
belgium
diabet
mellitu
dm
increasingli
common
human
cat
diabet
nephropathi
frequent
seriou
complic
human
diabet
patient
littl
known
cat
studi
compar
kidney
function
cat
dm
cat
chronic
kidney
diseas
ckd
healthi
cat
measur
routin
kidney
paramet
serum
creatinin
screat
serum
urea
surea
urinari
specif
graviti
usg
urinari
ratio
upc
glomerular
filtrat
rate
gfr
urinari
cystatin
c
ucysc
addit
paramet
compar
recent
month
recent
diagnos
diabet
cat
cat
dm
recent
recent
diagnos
cat
ckd
healthi
control
cat
prospect
recruit
gfr
evalu
clearanc
diabet
ckd
healthi
cat
cat
two
diabet
cat
ucysc
measur
human
nephelometr
immunoassay
valid
measur
felin
cystatin
c
express
ucyscurinari
creatinin
ratio
ucyscucreat
statist
analysi
perform
use
anova
diabet
cat
significantli
lower
screat
versu
ucyscucreat
versu
mgmol
significantli
higher
usg
versu
gfr
versu
mlminkg
compar
ckd
cat
compar
healthi
cat
diabet
cat
significantli
lower
usg
versu
none
evalu
paramet
significantli
differ
recent
recent
diagnos
diabet
cat
conclus
base
evalu
routin
kidney
paramet
gfr
ucysc
tubular
marker
felin
dm
neg
impact
kidney
function
conflict
interest
conflict
interest
report
b
al
wer
lj
veterinari
colleg
hatfield
unit
integr
genom
medic
research
univers
manchest
manchest
unit
kingdom
diabet
mellitu
common
endocrin
diseas
dog
requir
administr
exogen
insulin
control
hyperglycaemia
insulin
therapi
stimul
immun
respons
dog
develop
antibodi
aia
gener
immun
respons
would
requir
antigen
present
insulin
peptid
epitop
major
histocompat
complex
mhc
molecul
dog
encod
dog
leukocyt
antigen
dla
gene
hypothesi
current
studi
breed
differ
aia
reactiv
exist
might
reflect
dla
genet
influenc
antibodi
respons
insulin
therapi
blood
sampl
diabet
dog
recruit
via
uk
canin
diabet
regist
sera
made
avail
research
follow
complet
routin
diagnost
test
inform
owner
consent
indirect
elisa
bovin
porcin
insulin
use
determin
aia
statu
diabet
dog
n
diabet
dog
treat
n
lent
n
pzi
n
dla
allel
haplotyp
diabet
dog
determin
type
loci
three
diabet
dog
aia
posit
significantli
greater
insulin
reactiv
seen
diabet
dog
fifti
two
per
cent
diabet
dog
treat
insuvet
lent
aia
posit
compar
dog
treat
caninsulin
suggest
bovin
insulin
immunogen
porcin
insulin
greatest
insulin
reactiv
seen
insuvet
pzi
treat
dog
aia
posit
suggest
addit
protamin
enhanc
insulin
immunogen
breed
dachshund
cairn
terrier
miniatur
schnauzer
tibetan
terrier
like
develop
aia
wherea
cocker
spaniel
less
like
seroconvert
insulin
therapi
three
dla
haplotyp
appear
show
associ
aia
statu
associ
aia
posit
insuvet
dog
p
wherea
associ
aia
posit
dog
p
show
associ
aia
neg
p
result
suggest
dla
gene
might
influenc
aia
respons
treat
diabet
dog
variabl
dla
haplotyp
express
result
breed
differ
immun
respons
insulin
therapi
conflict
interest
studi
undertaken
alh
part
mre
degre
msd
anim
health
kennel
club
charit
trust
part
sponsorship
uk
companion
anim
diabet
regist
neither
fund
bodi
involv
conduct
studi
data
analysi
could
inappropri
influenc
bia
content
paper
mf
van
den
berg
mj
kool
ja
mol
hs
kooistra
galac
faculti
veterinari
medicin
utrecht
univers
utrecht
netherland
hypercortisol
due
adrenocort
tumor
character
hypersecret
cortisol
uncontrol
tumor
growth
lack
explan
process
still
character
autonom
transcript
factor
play
import
role
adren
develop
physiolog
oblig
activ
steroidogen
enzym
essenti
adrenocort
prolifer
studi
human
adrenocort
cell
cultur
transgen
mice
demonstr
increas
dosag
stimul
adrenocort
cell
prolifer
trigger
tumor
format
mice
suggest
modul
activ
may
repres
import
therapeut
target
at
report
screen
canin
at
carcinoma
adenoma
mrna
express
quantit
describ
associ
mrna
express
malign
clinic
outcom
addit
protein
express
local
determin
immunohistochemistri
ihc
fifteen
normal
canin
adren
serv
control
result
mrna
express
analysi
demonstr
signific
upregul
p
carcinoma
wherea
mrna
express
adenoma
differ
significantli
normal
adren
ihc
stain
predominantli
nuclear
whole
adren
cortex
at
stain
pattern
adenoma
carcinoma
differ
dog
avail
recurr
clinic
sign
hypercortisol
within
year
adrenalectomi
besid
biochem
confirm
hypercortisol
dog
metastasi
detect
diagnost
imag
group
dog
mrna
express
significantli
higher
p
dog
least
year
adrenalectomi
conclus
signific
upregul
adrenocort
carcinoma
associ
high
level
poor
outcom
post
adrenalectomi
suggest
role
pathogenesi
canin
at
research
focus
pharmacolog
modul
activ
warrant
might
provid
new
therapeut
approach
adren
hypercortisol
conflict
interest
conflict
interest
report
mmj
kool
galac
cg
spandauw
hs
kooistra
ja
mol
utrecht
univers
utrecht
netherland
cush
syndrom
hypercortisol
one
common
endocrinopathi
dog
adren
hypercortisol
result
adrenocort
adenoma
carcinoma
repres
case
spontan
hypercortisol
dog
character
adrenocorticotropin
acth
cortisol
hypersecret
lack
explan
mechan
lead
hypersecret
cortisol
character
autonom
normal
adren
cortex
cortisol
product
regul
melanocortin
receptor
signal
upon
acth
bind
stimulatori
g
protein
alpha
subunit
gsalpha
activ
adenylyl
cyclas
produc
cyclic
amp
camp
turn
activ
protein
kinas
pka
result
target
gene
transcript
activ
transcript
factor
subsequ
initi
steroidogenesi
aim
present
studi
investig
whether
hypersecret
cortisol
canin
at
may
result
aberr
activ
signal
pathway
mutat
analysi
perform
gene
encod
stimulatori
g
protein
alpha
subunit
gna
pka
regulatori
subunit
at
adenoma
carcinoma
deriv
dog
diagnos
hypercortisol
mutat
analysi
gna
show
presenc
differ
missens
mutat
known
abil
constitut
activ
pathway
activ
mutat
present
at
locat
codon
carcinoma
adenoma
codon
adenoma
codon
carcinoma
function
mutat
found
conclud
activ
camp
signal
mean
activ
gna
mutat
frequent
event
canin
at
like
play
crucial
role
cortisol
product
tumor
format
best
knowledg
first
report
potenti
causal
mutat
canin
at
conflict
interest
conflict
interest
report
ak
cook
texa
colleg
veterinari
medicin
biomed
scienc
colleg
station
unit
state
america
incident
adren
lesion
ial
routin
identifi
imag
studi
canin
patient
studi
describ
preval
ial
dog
undergo
ultrasonograph
us
examin
veterinari
radiologist
patient
demograph
outcom
also
report
report
us
exam
perform
texa
veterinari
medic
teach
hospit
januari
june
review
report
exclud
complet
examin
abdomin
caviti
perform
scan
perform
within
previou
month
adren
gland
classifi
abnorm
nodul
mass
describ
width
either
adren
mm
inform
regard
signal
clinic
find
outcom
collect
medic
record
patient
determin
ial
clinic
suspicion
adren
diseas
prior
imag
institut
adren
abnorm
appear
unrel
medic
problem
total
us
examin
perform
dog
met
inclus
criteria
ial
note
patient
distinct
nodulesmass
report
dog
enlarg
note
lesion
note
left
gland
right
gland
dog
vascular
invas
note
patient
gender
equal
repres
femal
male
bodi
weight
rang
kg
median
kg
age
rang
year
median
year
adrenalectomi
perform
dog
diagnos
includ
adenoma
carcinoma
pheochromocytoma
necropsi
examin
perform
find
includ
cortic
hyperplasia
cortic
adenoma
cortic
carcinoma
pheochromocytoma
cortic
atrophi
grossli
normal
proven
malign
mass
rang
size
mm
benign
lesion
mm
variou
contemporan
condit
report
includ
malign
patient
find
suggest
ial
dog
similar
preval
report
human
patient
often
note
dog
concurr
neoplast
diseas
base
small
data
set
ial
equal
like
benign
malign
although
mass
cm
probabl
malign
conflict
interest
conflict
interest
report
van
der
hp
e
hs
univers
utrecht
pet
nutrit
europ
pragu
czech
republ
felin
hyperthyroid
one
common
endocrin
disord
elderli
cat
current
three
treatment
option
avail
medic
ii
thyroidectomi
iii
radioiodin
therapi
recent
new
treatment
option
consist
food
introduc
manag
felin
hyperthyroid
previou
studi
show
food
safe
effect
method
decreas
circul
total
thyroxin
concentr
manag
hyperthyroid
research
coloni
object
studi
evalu
effect
food
circul
concentr
clinic
paramet
hyperthyroid
cat
prospect
studi
perform
two
hundr
hyperthyroid
cat
enrol
studi
transit
food
data
questionnair
complet
veterinarian
owner
record
week
well
circul
urea
creatinin
concentr
studi
group
consist
male
femal
median
age
year
rang
year
one
group
n
previous
diagnos
treat
drug
group
n
includ
newli
diagnos
cat
circul
concentr
decreas
within
refer
rang
week
p
chang
significantli
week
significantli
cat
increas
week
poor
owner
complianc
andor
palat
compar
cat
normal
indic
factor
may
respons
less
desir
result
cat
clinic
paramet
vomit
pupd
hyperact
polyphagia
weight
loss
hair
coat
qualiti
qualiti
life
improv
week
p
circul
creatinin
concentr
significantli
p
decreas
week
week
may
explain
lower
meat
content
food
compar
regular
cat
food
signific
differ
observ
previous
diagnos
newli
diagnos
cat
common
report
reason
incomplet
data
poor
palat
food
owner
complianc
side
effect
detect
conclus
cat
hyperthyroid
food
valuabl
manag
option
normal
circul
concentr
improv
symptom
sign
hyperthyroid
within
week
refer
melendez
ld
et
al
titrat
dietari
iodin
reduc
serum
thyroxin
concentr
newli
diagnos
hyperthyroid
cat
ecvim
forum
abstract
conflict
interest
van
der
kooij
receiv
studi
grant
hill
pet
nutrit
europ
complet
manuscript
iveta
hein
p
meyer
employe
hill
pet
nutrit
europ
conflict
interest
report
l
e
f
p
p
de
fregi
arcueil
epidemiolog
biostatist
unit
nation
veterinari
school
alfort
maison
alfort
patholog
unit
nation
veterinari
school
alfort
maison
alfort
vet
referr
centr
creteil
franc
hyperthyroid
common
endocrin
disord
geriatr
cat
sever
treatment
modal
use
diseas
includ
radioiodin
individu
dose
determin
use
radiotrac
kinet
studi
score
system
fix
rel
high
dose
ie
mci
administr
effect
associ
prolong
surviv
time
latter
method
less
complic
potenti
expos
patient
veterinari
personnel
unnecessari
level
radiat
aim
studi
retrospect
evalu
efficaci
fix
low
dose
mean
sd
mci
treatment
hyperthyroid
cat
assess
outcom
identifi
factor
associ
surviv
medic
record
one
singl
referr
centr
retrospect
examin
follow
data
collect
diagnosi
avail
serum
total
thyroxin
urea
creatinin
concentr
alpk
alt
activ
addit
age
sex
weight
admiss
reason
prior
treatment
antithyroid
drug
record
death
whatev
caus
event
surviv
analysi
median
surviv
time
mst
determin
method
admiss
day
multivari
cox
model
use
investig
independ
risk
factor
death
cat
includ
studi
male
femal
ratio
median
age
admiss
year
interquartil
rang
iqr
median
initi
time
week
iqr
diagnosi
serum
concentr
alkp
alt
activ
refer
rang
cat
respect
cat
serum
creatinin
concentr
refer
rang
diagnosi
serum
concentr
alkp
alt
activ
upper
rang
valu
cat
respect
serum
creatinin
concentr
refer
rang
identifi
cat
mst
year
surviv
rate
therapi
respect
low
bodi
weight
kg
adjust
hazard
ratio
ahr
confid
interv
ci
p
male
gender
ahr
ci
p
independ
associ
death
wherea
age
prior
treatment
drug
azotemia
studi
suggest
rel
fix
low
dose
treatment
effect
felin
hyperthyroid
surviv
achiev
consid
caus
death
low
bodi
weight
male
gender
significantli
associ
shorter
surviv
time
conflict
interest
conflict
interest
report
corradini
floriano
f
dondi
pfb
f
fracassi
univers
bologna
ozzano
dellemilia
itali
pituitari
depend
hypercortisol
pdh
one
frequent
endocrinopathi
dog
prognost
factor
larg
unknown
aim
present
studi
determin
prognost
valu
differ
clinic
clinicopatholog
variabl
evalu
time
diagnosi
treatment
dog
pdh
medic
record
one
referr
center
retrospect
evalu
diagnosi
hypercortisol
confirm
use
ldd
test
andor
acth
stimul
test
dog
compat
clinic
sign
differenti
adren
depend
hypercortisol
pdh
base
ultrasonograph
appear
adren
gland
result
ldd
test
concentr
endogen
acth
newli
diagnos
dog
pdh
subsequ
treat
trilostan
includ
follow
variabl
enter
univari
cox
regress
analysi
determin
associ
surviv
age
sex
neuter
statu
clinic
sign
concomit
diseas
hypertens
statu
serum
cortisol
concentr
routin
biochem
haematolog
paramet
urin
specif
graviti
urin
protein
creatinin
ratio
upc
urin
albumin
creatinin
ratio
uac
show
possibl
associ
p
surviv
includ
stepwis
multivari
cox
regress
analysi
statist
signific
set
p
dog
elig
inclus
studi
median
age
diagnosi
year
rang
male
castrat
femal
spay
median
surviv
time
day
rang
variabl
relat
surviv
age
urea
potassium
phosphat
lymphocyt
basal
serum
cortisol
concentr
multivari
model
surviv
associ
serum
potassium
p
phosphat
p
concentr
hyperphosphatemia
observ
case
median
phosphat
mgdl
rang
hyperkalemia
dog
median
potassium
meql
rang
phosphat
concentr
posit
correl
cortisol
concentr
r
p
alanin
aminotransferas
r
p
gamma
glutamyl
transferas
activ
r
p
neg
correl
total
calcium
concentr
r
p
urinari
specif
graviti
r
p
potassium
concentr
posit
correl
serum
alkalin
phosphatas
activ
r
p
conclud
serum
phosphat
potassium
concentr
appear
prognost
import
dog
pdh
upc
appear
unrel
surviv
canin
pdh
unalik
dog
chronic
kidney
diseas
despit
mark
proteinuria
associ
diseas
conflict
interest
conflict
interest
report
c
c
k
maximilian
univers
munich
anim
clinic
haar
haar
germani
trilostan
medic
treatment
choic
dog
hyperadrenocortic
regular
treatment
monitor
recommend
dose
adjust
mainli
base
upon
result
acth
stimul
test
howev
discrep
result
acth
stimul
test
clinic
respons
treatment
sometim
observ
aim
studi
investig
associ
acth
stimul
test
result
baselin
cortisol
concentr
clinic
laboratori
paramet
dog
hyperadrenocortic
current
treat
trilostan
base
upon
consult
endocrinolog
expert
standard
oper
procedur
protocol
questionnair
owner
concern
sever
clinic
sign
develop
dog
hyperadrenocortic
twenti
five
dog
hyperadrenocortic
treat
trilostan
includ
sixtyon
event
dog
consist
histori
owner
questionnair
physic
exam
find
complet
blood
count
biochem
profil
urinalysi
acth
stimul
test
result
collect
use
spearman
rank
correl
coeffici
correl
baselin
cortisol
concentr
clinic
laboratori
paramet
calcul
correl
baselin
cortisol
cortisol
concentr
r
p
n
correl
clinic
sign
laboratori
paramet
neither
baselin
cortisol
concentr
acth
stimul
test
reflect
control
clinic
sign
therefor
dose
adjust
trilostan
base
result
acth
stimul
test
howev
acth
stimul
test
still
method
assess
overdos
trilostan
risk
iatrogen
hypocortisol
conflict
interest
conflict
interest
report
mr
kr
dm
state
univers
lans
unit
state
biomed
laboratori
unit
state
america
case
hypoadrenocortic
hoac
human
result
adren
commerci
avail
assay
use
recombin
human
antigen
use
screen
tool
identif
autoantibodi
ab
serum
presenc
ab
constitut
primari
criteria
earli
diagnosi
adren
dog
test
commerci
avail
use
recombin
canin
antigen
western
blot
wb
immunosorb
assay
elisa
previous
abl
show
approxim
dog
natur
occur
primari
hoac
measur
ab
limit
studi
small
sampl
size
differ
optic
densiti
od
elisa
specif
bind
nonspecif
bind
nsb
narrow
aim
present
studi
decreas
nsb
od
without
decreas
specif
od
overarch
goal
improv
perform
ab
elisa
achiev
sera
one
dog
immun
canin
use
neg
posit
control
use
combin
four
differ
amount
canin
plate
coat
differ
block
buffer
eight
differ
assay
buffer
compar
best
combin
establish
total
serum
sampl
dog
hoac
serum
sampl
healthi
dog
dog
hyperadrenocortic
receiv
treatment
mitotan
n
trilostan
n
analysedco
elisa
plate
use
sodium
bicarbon
ph
contain
recombin
purifi
canin
gave
adequ
od
increas
concentr
increas
od
use
commerci
protein
block
buffer
significantli
decreas
nsb
od
without
decreas
specif
od
posit
effect
enhanc
use
particular
proprietari
assay
buffer
consid
od
calcul
upper
limit
healthi
dog
posit
dog
hoac
classifi
true
posit
one
healthi
dog
classifi
show
elisa
high
specif
low
sensit
includ
dog
hyperadrenocortic
calcul
number
chang
slightli
respect
data
suggest
elisa
current
form
provid
high
level
confid
posit
result
therefor
strongli
believ
assay
potenti
assist
earli
diagnosi
adren
dog
conflict
interest
dr
callewaert
ms
rader
employ
commerci
biotechnolog
compani
e
la
ik
anim
hospit
univers
glasgow
glasgow
unit
glasgow
glasgow
unit
kingdom
canin
hypoadrenocortic
routin
treat
long
term
fludrocortison
acet
europ
littl
research
pharmacokinet
fludrocortison
opinion
vari
start
dose
frequenc
studi
compar
stabilis
three
group
dog
primari
hypoadrenocortic
start
continu
daili
sid
dose
start
continu
twice
daili
bid
dose
start
sid
switch
bid
case
primari
hypoadrenocortic
confirm
acth
stimul
includ
retrospect
studi
provid
start
fludrocortison
follow
data
avail
week
includ
electrolyt
record
dosag
chang
time
taken
month
stabilis
chang
treatment
record
dog
stabilis
defin
normal
electrolyt
concentr
clinic
evalu
dose
regimen
fludrocortison
determin
individu
clinician
gender
age
diagnosi
breed
predisposit
dose
frequenc
examin
surviv
curv
cox
proport
hazard
model
four
dog
start
sid
dose
fail
stabilis
studi
period
includ
two
dog
subsequ
unsuccess
switch
bid
dose
dog
remain
elig
exclus
median
time
whole
cohort
becom
stabl
diagnosi
month
interquartil
rang
iqr
month
dog
start
continu
sid
dose
n
median
stabilis
period
month
iqr
month
dog
start
continu
bid
dose
n
median
stabilis
period
month
iqr
month
ten
dog
fail
stabilis
sid
dose
median
time
month
iqr
month
switch
bid
dose
subsequ
found
stabilis
median
time
month
chang
dose
frequenc
dog
studi
chang
bid
sid
dose
signific
differ
stabilis
time
sid
bid
group
howev
chang
sid
bid
stabilis
time
significantli
quicker
either
group
breed
age
gender
includ
model
confound
statist
signific
differ
identifi
studi
suggest
larger
studi
would
use
dog
treat
sid
stabilis
quickli
may
rapidli
stabilis
use
bid
dose
conflict
interest
conflict
interest
report
